DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TRAV19; CD300LB; DNASE2; NCR3; TYROBP; LILRA1; NCR1; NCR2; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; TRBV12-3; TRAV8-4; IGHV1-46; IGHV3-23; IGHV3-13; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGKC; TRBC1; HLA-B; HLA-H; IGLV7-43; CD3D; IGKV1-16; IGKV3-11; TRBV7-9; TRAV29DV5; HLA-A; IGKV2-30; IGKV4-1; IGHV4-34; CD3G; IGLC2; IGLC3; HLA-C; CD8B; IFITM1; HLA-E; CD19; VCAM1; IGHV1-2; KLRC1; CD40LG; HLA-F; ICAM3; CD200; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; B2M; IGLV3-21; CD300C; CD300E; TREML2; CD276; LAIR1; LAIR2; CLEC4G; TREML4; JAML; TREML1; LILRB2; LILRB1; CD300LF; KIR2DL4; HCST; CD300A; PILRA; SIGLEC7; BTNL8; BTN2A2; BTN1A1; HHLA2;	GO:0050776~regulation of immune response	86	216	39.8148148148148	0	0	0	0	0	0	0
down	ALOX12B; TH; PSAPL1; SPNS2; ACER1; ALOXE3;	GO:0006665~sphingolipid metabolic process	6	19	31.5789473684211	0.00010238996506006	0.00452267253561379	0.336043865327143	0.343723112706648	0.300500836198117	0.336043865327143	0.0393299183560244
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.00010881628156633	0.00466220352427032	0.357026219819153	0.365296257218195	0.311976279250689	0.357026219819153	0.040543303218356
up	IFNG; HLA-B; HLA-H; HLA-DRA; HLA-A; HLA-DPB1; HLA-C; IRF1; HLA-E; IRF2; IFNGR1; VCAM1; HLA-DPA1; SP100; PML; HLA-F; IFNGR2; B2M; IRF9; IRF8; PRKCD; NMI; IRF3; IRF4; FCGR1B; TRIM34; TRIM8;	GO:0060333~interferon-gamma-mediated signaling pathway	27	72	37.5	0.00012225664673914	0.0485171238722632	0.660797175625103	0.662264255385973	0.660430405684886	0.660797175625103	0.445125466657917
up	LYN; MS4A1; CD19; CTLA4; PTPN6; MNDA; NCKAP1L; RFTN1; LAT2; IGHV4-34; IGHV3-21; IGHV4-39; IGHV1-2; IGHV2-5; IGLL5; IGLC3; IGHV3-35; IGHV3-43; IGHV3-30; IGHV3-13; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV1-46; IGHV6-1; IGHV1-18; IGHV3-16; TRBC1; TRDC; IGHE; IGHD; IGHV3-15; IGLC2; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	39	125	31.2	0.00012539038844594	0.0485171238722632	0.677609659161887	0.679239734211684	0.677358878384995	0.677609659161887	0.445125466657917
down	CLDN7; TF; EPCAM; DUOXA2; CCL19; DUOX2;	GO:2000147~positive regulation of cell motility	6	20	30	0.00012956475871528	0.00542651976552697	0.4247132790687	0.434948895007207	0.347363118115676	0.4247132790687	0.0471899253494292
down	UNC13B; CACNA1G; SNCG; HTR3B; SLC6A1; SLC1A3; LPAR3; PCDHB10; PCDHB5; PCDHB11; GABRA4; GABRB3; GABRQ; GABRE; GABRB2; CHRNB4; GABRG1; DLG2; GABRA3; GABRR1; GABRD;	GO:0007268~chemical synaptic transmission	21	249	8.43373493975904	0.00015183999173207	0.00621618112493374	0.497427812914269	0.509726852244567	0.381624434966041	0.497427812914269	0.0540569528757014
up	HP; HPR; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-23; IGHV3-13; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGKC; IGLV7-43; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; ASGR1; CD14; IGLC2; IGLC3; FOLR2; IGHV1-2; TGFBR2; PPT1; HBA1; IGLV3-21; LRP2; CLN3; SNX17; LDLRAP1; LMBR1L; FCGR1B; CXCL16; DAB2;	GO:0006898~receptor-mediated endocytosis	46	160	28.75	0.00016422248892944	0.0593062148353866	0.887294107685787	0.889593222530799	0.887129885196857	0.887294107685787	0.544111118866386
down	CXCL11; DEFB4A; GPR37; RAMP3; RGS11; ADGRL2; CXCL10; ANXA1; CCK; ADRA2A; SAA1; EDN3; PDE6A; ADCYAP1; ADRA2C; EDN2; EDNRB; BDKRB2; AGTR1; PTGER1; APLNR; ADCYAP1R1; GPR1; BDKRB1; NMU; AKR1C2; PDE1A; DEFB1; GNAI1; CX3CL1; CXCL9; GPR17; ACKR1; FFAR4; ADGRF1; ARHGEF16; RGS7BP; PREX2; ADGRG6; ARHGEF25; ADGRF5; ADGRF4; ADGRF2; NGEF; OR2I1P; ADGRV1; QRFPR; CCL19; GPR62; ADGRL4; ARHGEF4; LPAR3; RAPGEFL1; FZD10; GNG4; CCL11; CGB7; GPR87; MRGPRX3; GPR78; GNG12; CCL17;	GO:0007186~G protein-coupled receptor signaling pathway	62	1152	5.38194444444444	0.00016861259282352	0.00681966836275389	0.552206241497044	0.566032474108573	0.405850510926224	0.552206241497044	0.0593049790384331
down	TCF21; ID1; FOXF1; STRA6;	GO:0060426~lung vasculature development	4	6	66.6666666666667	0.00017682485070091	0.00706667885479742	0.578924561194807	0.593601023802983	0.4158655736061	0.578924561194807	0.0614530236754599
down	DSG1; TJP1; CDH19; CDH8; PKP3; PKP1; CDH17; CTNND1;	GO:0007043~cell-cell junction assembly	8	43	18.6046511627907	0.00018180440690063	0.00718020463488731	0.595045823785768	0.610317393965421	0.421907825842648	0.595045823785768	0.0624402628857012
down	GABRB2; GABRA4; GABRG1; GABRA3; GABRE;	GO:0051932~synaptic transmission, GABAergic	5	13	38.4615384615385	0.00018735002467507	0.00731318642830478	0.61300928073683	0.628934032834211	0.428656856456561	0.61300928073683	0.0635966948486085
up	PSMB11; NFATC1; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-23; IGHV3-13; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGKC; IGHE; IGLV7-43; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; LYN; IGLC2; IGLC3; IGHV1-2; PSMA2; PSMB8; PSMB9; FCER1G; PSMB10; PSMB3; LILRA4; GRB2; IGLV3-21; RELA; PSME1; NFATC3; PSMA8; PSMF1; LAT2;	GO:0038095~Fc-epsilon receptor signaling pathway	48	171	28.0701754385965	0.00019206912247671	0.0650274022785219	1	1	0.96687596254777	0.99999941022145	0.596600756075053
down	FGF1; ADRA2A; ADRA2C; NTF3; WNT5A; IL18; DYNAP;	GO:0032148~activation of protein kinase B activity	7	32	21.875	0.0001930528935452	0.00744917889231341	0.631476014786379	0.648078563631267	0.435527327837992	0.631476014786379	0.0647793081075559
down	HOXB1; HOXD10; HOXD3; HOXA6; HOXA7; HOXD9; HOXD4; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	8	44	18.1818181818182	0.00020896720254071	0.0079716238514678	0.683322752308124	0.701502898929166	0.45380544466854	0.683322752308124	0.0693225770325677
down	RAMP3; ALOX12B; DKK1; AGR2; BMP2; BMP7; ERBB3; HOXD3; ID1; WNT5A; LCN2; POU3F1; PKP1; NR0B2; OCLN; IL34; SLC26A9; CAMK2N1; SEC16B; OVOL2; TRIM6; EPB41L4B; PKP3; IL1F10; IL36A; IL36G; IL36B;	GO:0010628~positive regulation of gene expression	27	374	7.2192513368984	0.00021330693064214	0.00804574568725477	0.697300356269166	0.716071366165674	0.458540895727748	0.697300356269166	0.0699671529391681
down	SAA1; EDN2; EDNRB; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	5	14	35.7142857142857	0.00024767203954856	0.00913664875565414	0.809144553205156	0.831435036764527	0.493483303860666	0.809144553205156	0.0794538288540453
down	C1QA; C1QB; C1QC; SLPI; ANXA1; S100B; S100A8; S100A9; KRT16; SAA1; MIF; S100A7; CRISP3; DEFB1; LCN2; MST1R; TRIM29; COLEC12; SUSD4; IL34; TRIL; NLRP10; CLEC10A; PGLYRP4; PGLYRP3; RARRES2; TRIM31; RNASE7; IL1RL2; IL36B; IL36G; IL36RN; IL36A;	GO:0045087~innate immune response	33	505	6.53465346534654	0.00025812953156179	0.00941892214622751	0.843051050080807	0.86654083745293	0.502798369395693	0.843051050080807	0.0819085255666433
down	OVOL1; GJB3; KRT9; DHCR24; TFAP2B; ABCB6; DSP;	GO:0043588~skin development	7	34	20.5882352941176	0.00026712637266201	0.00955695356262617	0.872167606741491	0.896743233026397	0.51074562452978	0.872167606741491	0.0831088698972967
down	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.00027092609534951	0.00955695356262617	0.884302775220803	0.909498902088308	0.514121000983493	0.884302775220803	0.0831088698972967
down	GJB6; CXCL14; C1QB; BMP2; GJB2; HPCA; ADGRV1; CYTL1;	GO:0048839~inner ear development	8	46	17.3913043478261	0.00027329983378376	0.00955695356262617	0.891777357636438	0.917467542012112	0.516263386017539	0.891504057802654	0.0831088698972967
down	DEFB4A; CXCL10; SAA1; SAA2; MIF; NTF3; CX3CL1; GPNMB;	GO:0050918~positive chemotaxis	8	46	17.3913043478261	0.00027329983378376	0.00955695356262617	0.891777357636438	0.917467542012112	0.516263386017539	0.891504057802654	0.0831088698972967
down	CLDN4; CLDN1; ANXA1; ADRA2A; OCLN; DUOX2;	GO:0090303~positive regulation of wound healing	6	24	25	0.00030003123114208	0.0101737862923634	0.977801782292051	1	0.539447143953147	0.977801782292051	0.0884729506944036
down	MUC1; MUC3A; MUC21; B3GNT6; MUC15; MUCL1; MUC13; A4GNT; B3GNT3;	GO:0016266~O-glycan processing	9	60	15	0.00030931821455582	0.0103838124626389	1	1	0.546610633870361	0.999999169059752	0.0902993734708744
down	IL20RB; IL36A; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.00036216959845891	0.0115790794478722	1	1	0.57838484873889	0.999999169059752	0.100693615497619
down	CYP2C9; CYP2C19; CYP2F1; CYP2J2; CYP2C18; CYP2E1;	GO:0042738~exogenous drug catabolic process	6	25	24	0.00036216959845891	0.0115790794478722	1	1	0.57838484873889	0.999999169059752	0.100693615497619
down	MT1A; MT1E; MT1G; MT1H; MT1X; MT1M;	GO:0071294~cellular response to zinc ion	6	25	24	0.00036216959845891	0.0115790794478722	1	1	0.57838484873889	0.999999169059752	0.100693615497619
down	GJB6; GJB1; GJA1; GJB2;	GO:0016264~gap junction assembly	4	8	50	0.00039624818022887	0.0124318237479284	1	1	0.59770745497926	0.999999169059752	0.108109222848289
down	AQP1; SCNN1A; SCNN1B; SCNN1G;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.00039624818022887	0.0124318237479284	1	1	0.59770745497926	0.999999169059752	0.108109222848289
down	CSTA; CSTB; SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.00041128110649646	0.0125515515864421	1	1	0.605817069869291	0.999999169059752	0.10915039619803
down	ALOX15B; ALOX12B; PON3; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	5	16	31.25	0.00041128110649646	0.0125515515864421	1	1	0.605817069869291	0.999999169059752	0.10915039619803
down	EDN3; EDN2; KEL; EDNRB; BDKRB2;	GO:0042310~vasoconstriction	5	16	31.25	0.00041128110649646	0.0125515515864421	1	1	0.605817069869291	0.999999169059752	0.10915039619803
down	FOXP2; ELN; HOXD9; HOXD10; MEOX2; MYH14; VGLL2; MYOZ1;	GO:0007519~skeletal muscle tissue development	8	50	16	0.00045058399228714	0.0136271212802518	1	1	0.62322441702285	0.999999169059752	0.118503730517648
up	TNIP2; TLR9; IGHV3-16; IGHV3-49; IGLC3; IGHV3-15; IGHV4-39; IGHV3-21; IGHD; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; TRBC2; IGHG2; IGHE; IGLC2; IGHV1-46; IGHV5-51; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-7; TRDC; IGKC; IGHV3-35; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	31	98	31.6326530612245	0.00048278392774925	0.153837678624571	1	1	0.999999410221451	0.99999941022145	1
down	GFRA3; NFASC; ERBB3; EDNRB; NTF3; NTF4;	GO:0007422~peripheral nervous system development	6	27	22.2222222222222	0.00051630876406483	0.0154754332229075	1	1	0.648043283205056	0.999999169059752	0.13457696094251
down	PLPP2; ALDH3B2; DEGS2; CERS3; SGPP2; SPTSSB; ACER1; SPTLC3;	GO:0030148~sphingolipid biosynthetic process	8	52	15.3846153846154	0.0005690258091574	0.0166106055768819	1	1	0.666729066241952	0.999999169059752	0.144448609984147
down	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.00058067253024263	0.0168044627933148	1	1	0.67067677243024	0.999999169059752	0.146134424828134
down	BMP2; BMP7; WNT5A; WNT4; FOXF2; AKNAD1; FAM83D;	GO:0001837~epithelial to mesenchymal transition	7	40	17.5	0.00063415452077497	0.0177591146145595	1	1	0.688832322270719	0.999999169059752	0.154436237062455
down	CES2; GSTA1; AKR1C2; PTGR1; AKR1C1;	GO:0006693~prostaglandin metabolic process	5	18	27.7777777777778	0.00064540124604595	0.0177591146145595	1	1	0.692664783146712	0.999999169059752	0.154436237062455
down	ALOX12B; GSTA1; CYP2J2; ALOXE3; ALOX15B;	GO:0043651~linoleic acid metabolic process	5	18	27.7777777777778	0.00064540124604595	0.0177591146145595	1	1	0.692664783146712	0.999999169059752	0.154436237062455
down	DSP; KRT9; KRT20; KRT17; TCHH;	GO:0045109~intermediate filament organization	5	18	27.7777777777778	0.00064540124604595	0.0177591146145595	1	1	0.692664783146712	0.999999169059752	0.154436237062455
down	UPK2; WNT9B; SPDEF; FGF1; HOXD4; EDN3; HOXB1; FLG; MEOX2; ELF3; CSRP2; ODF4; SPATA19; CCL17; PAQR5; EHF; NPAP1; THEG; DKK4; NKX1-2; GTF2IRD1; EPHA2; TYRO3; FGFR3; CDH19; CDH8; ERBB3; MST1R; SPINK6; CDH17; KDR; SPINK5;	GO:0007275~multicellular organism development	32	513	6.23781676413255	0.00066579416743606	0.0181713091063647	1	1	0.699749669975302	0.999999169059752	0.158020749445751
down	PHGDH; AKR7A3; IDO1; GPX2; MAOB; XDH; ME1; NOX4; NDUFA4L2;	GO:0022900~electron transport chain	9	68	13.2352941176471	0.00070364861878724	0.019049583977974	1	1	0.712628149060512	0.999999169059752	0.165658374925495
down	CXCL11; CXCL10; APLNR; BDKRB1; CX3CL1; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	6	29	20.6896551724138	0.00071713691994257	0.0192594291219778	1	1	0.717136919942574	0.999999169059752	0.167483223467167
down	UNC13B; GABRB3; NTF4; GABRB2; SLITRK6;	GO:0060384~innervation	5	19	26.3157894736842	0.00079420547485065	0.0211599030085209	1	1	0.743376324460209	0.999999169059752	0.184010062898259
down	ALOX15B; BRINP1; INHA; BMP2; BMP7; ADCYAP1; CAMK2N1;	GO:0045786~negative regulation of cell cycle	7	42	16.6666666666667	0.00082014522852125	0.0216789569460303	1	1	0.752124384120529	0.999999169059752	0.18852384293072
down	MT1X; MT1A; MT1H; MT1E; MT1G; MT1M;	GO:0006882~cellular zinc ion homeostasis	6	30	20	0.00083781062181453	0.0219728926361829	1	1	0.758218612742158	0.999999169059752	0.191079956955026
down	CXCL11; CXCL10; CX3CL1; GPR17; ACKR1; CCL11; CXCL9; CCL17; CCL19;	GO:0070098~chemokine-mediated signaling pathway	9	70	12.8571428571429	0.00084885588261818	0.0220899937825522	1	1	0.761588157520126	0.999999169059752	0.192098288149654
down	ADGRL2; CXCL10; INHA; EDN3; MIF; EDN2; EDNRB; BDKRB2; ADCYAP1R1; ADGRF1; ADGRG6; ADGRF5; ADGRF4; ADGRF2; CLEC1A; ADGRV1; MAGI1; ADGRL4; CBLC; ANXA1;	GO:0007166~cell surface receptor signaling pathway	20	268	7.46268656716418	0.0009090518274698	0.0234745152678165	1	1	0.777808467387095	0.999999169059752	0.204138319027153
down	CTNND1; JUP; DSP; CDH8; CDH17; NECTIN4; CDH19;	GO:0034332~adherens junction organization	7	43	16.2790697674419	0.00092799973506085	0.0236007205348432	1	1	0.782826505392584	0.999999169059752	0.205235821180841
down	SCGB1A1; IDO1; GPNMB; IL20RB; VTCN1; FOXJ1; PLA2G2A;	GO:0042130~negative regulation of T cell proliferation	7	43	16.2790697674419	0.00092799973506085	0.0236007205348432	1	1	0.782826505392584	0.999999169059752	0.205235821180841
down	GLI2; HOXB1; SOSTDC1; GRHL3; SHROOM3; FOXJ1;	GO:0007389~pattern specification process	6	31	19.3548387096774	0.0009735455729305	0.0237945830108661	1	1	0.794916243055535	0.999999169059752	0.206921681763104
down	NRG2; ERBB3; BTC; PTK6; GRB7; PTPRR;	GO:0038128~ERBB2 signaling pathway	6	31	19.3548387096774	0.0009735455729305	0.0237945830108661	1	1	0.794916243055535	0.999999169059752	0.206921681763104
down	PLPP2; PLA2G2A; PLA2G4E; TNFAIP8L3; PLA2G4F; PLA2G4D; PLA2G3; GDPD3;	GO:0006644~phospholipid metabolic process	8	57	14.0350877192982	0.00097747282937665	0.0237945830108661	1	1	0.79581092606363	0.999999169059752	0.206921681763104
down	EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.00099232696500484	0.0237945830108661	1	1	0.799785362325119	0.999999169059752	0.206921681763104
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.00099232696500484	0.0237945830108661	1	1	0.799785362325119	0.999999169059752	0.206921681763104
down	ANXA8; PLA2R1; ANXA1;	GO:1900138~negative regulation of phospholipase A2 activity	3	4	75	0.00099232696500484	0.0237945830108661	1	1	0.799785362325119	0.999999169059752	0.206921681763104
down	TJP1; OCLN; TJP2;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.00099232696500484	0.0237945830108661	1	1	0.799785362325119	0.999999169059752	0.206921681763104
up	IFNA21; IFNA5; IFNB1; HLA-B; HLA-H; HLA-A; HLA-C; IRF1; IFITM1; HLA-E; IRF2; SP100; PSMB8; TYK2; HLA-F; IFNAR2; IRF9; IFITM2; IRF8; IRF3; IRF4; ISG20; MYD88;	GO:0060337~type I interferon signaling pathway	23	67	34.3283582089552	0.00100932868702541	0.287764920927193	1	1	0.999999410221451	0.99999941022145	1
down	FUT1; FUT3; FUT2; FUT6;	GO:0036065~fucosylation	4	11	36.3636363636364	0.00101308225387209	0.0240549259160624	1	1	0.804821596509407	0.999999169059752	0.20918566729938
down	WNT9B; CTSV; KRT20; WNT4; DSC2; CADPS2; MFSD2A; WNT2B; MYH13;	GO:0009267~cellular response to starvation	9	72	12.5	0.00101751548408724	0.0240549259160624	1	1	0.805872263397093	0.999999169059752	0.20918566729938
down	SLC6A15; SLC6A17; SLC6A14; SLC6A1; SLC6A11; TMEM184A;	GO:0006810~transport	6	32	18.75	0.00112555882858323	0.0258801437503692	1	1	0.823472247487181	0.999999169059752	0.225058067487536
down	TJP1; CNN3; MYH14; EPB41L4B; LIMCH1; FRMD6;	GO:0031032~actomyosin structure organization	6	32	18.75	0.00112555882858323	0.0258801437503692	1	1	0.823472247487181	0.999999169059752	0.225058067487536
down	SRPX2; ANXA1; KDR; FGFBP1; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.00116658663649349	0.0266410295150249	1	1	0.828908266705589	0.999999169059752	0.23167485761915
down	CYP1A1; GLI2; BMP2; FOXF1; KLF5; IL18; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	7	45	15.5555555555556	0.00117702858336866	0.0266978713133012	1	1	0.830261285699949	0.999999169059752	0.232169163423475
down	FABP5; SLC44A4; SLC44A3; MFSD2A; SLC44A5; LPIN3;	GO:0006656~phosphatidylcholine biosynthetic process	6	33	18.1818181818182	0.00129510536227428	0.0283992678002113	1	1	0.845872164354261	0.999999169059752	0.246964792422585
down	AQP1; AQP5; PAX9; AQP3; PITX2; TUFT1;	GO:0042476~odontogenesis	6	33	18.1818181818182	0.00129510536227428	0.0283992678002113	1	1	0.845872164354261	0.999999169059752	0.246964792422585
down	CTSG; CPA3; CMA1; ACE2;	GO:0002003~angiotensin maturation	4	12	33.3333333333333	0.00131722046833627	0.0283992678002113	1	1	0.848895951208989	0.999999169059752	0.246964792422585
down	GPIHBP1; MFSD2A; MAL2; RAB17;	GO:0045056~transcytosis	4	12	33.3333333333333	0.00131722046833627	0.0283992678002113	1	1	0.848895951208989	0.999999169059752	0.246964792422585
down	FGF1; ADRA2A; EDN3; MIF; MST1R; TPD52L1; EPGN; NOX4;	GO:0043406~positive regulation of MAP kinase activity	8	60	13.3333333333333	0.00131769759492251	0.0283992678002113	1	1	0.848895951208989	0.999999169059752	0.246964792422585
down	CTSV; S100B; SCGB1A1; IGFBP2; AGXT; ALDH3A1; WNT7B; HSD11B2;	GO:0051384~response to glucocorticoid	8	60	13.3333333333333	0.00131769759492251	0.0283992678002113	1	1	0.848895951208989	0.999999169059752	0.246964792422585
down	WNT9B; DKK1; LRAT; GJA1; IGFBP2; GJB2; AQP3;	GO:0032526~response to retinoic acid	7	46	15.2173913043478	0.00131971575121625	0.0283992678002113	1	1	0.849238502405187	0.999999169059752	0.246964792422585
down	FOXP2; TCF21; EDN2; FOXF1; ABCA12; STRA6;	GO:0048286~lung alveolus development	6	34	17.6470588235294	0.00148347555315675	0.0315191609616913	1	1	0.870824497784048	0.999999169059752	0.274095906239533
down	AQP1; RHBG; RHCG;	GO:0015696~ammonium transport	3	5	60	0.00155051961706665	0.0319308177213484	1	1	0.879880691247593	0.999999169059752	0.277675742413947
down	CD1A; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	3	5	60	0.00155051961706665	0.0319308177213484	1	1	0.879880691247593	0.999999169059752	0.277675742413947
down	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.00155051961706665	0.0319308177213484	1	1	0.879880691247593	0.999999169059752	0.277675742413947
down	SCNN1B; SCNN1G; FXYD3; SLC5A12; SLC10A6; SLC5A8; SLC38A3; SLC6A15; SLC5A1;	GO:0006814~sodium ion transport	9	77	11.6883116883117	0.00155992079425116	0.0319308177213484	1	1	0.881311444034368	0.999999169059752	0.277675742413947
down	ADRA2A; AGTR1; EPS8L1; EPS8L2; RHOD; CDC42EP5; RHOV; C15orf62; RND3;	GO:0007266~Rho protein signal transduction	9	77	11.6883116883117	0.00155992079425116	0.0319308177213484	1	1	0.881311444034368	0.999999169059752	0.277675742413947
down	SMIM22; EFNA5; GRHL3; FZD10; ARHGAP40; RND3; ARHGAP28; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	9	77	11.6883116883117	0.00155992079425116	0.0319308177213484	1	1	0.881311444034368	0.999999169059752	0.277675742413947
down	KLK8; GJA1; BMP7; WNT7B; NYAP1; NTF3; NTF4; NCKAP1;	GO:0048812~neuron projection morphogenesis	8	62	12.9032258064516	0.00159250045379811	0.0324001455963651	1	1	0.885430252311747	0.999999169059752	0.281757096273034
down	SNCG; CSTB; HOXD9; HOXD10; NTF4; PREX2; SLITRK6;	GO:0008344~adult locomotory behavior	7	48	14.5833333333333	0.00164538867225283	0.0332745167033299	1	1	0.892443398643669	0.999999169059752	0.28936077396117
down	CPZ; CPXM1; CPXM2; CPE;	GO:0006518~peptide metabolic process	4	13	30.7692307692308	0.00167977725681356	0.033413588976387	1	1	0.897001055138443	0.999999169059752	0.29057016975577
down	EDN2; NMU; PRKAA2; IRX3; MFSD2A; MRAP2;	GO:0097009~energy homeostasis	6	35	17.1428571428571	0.00169199255546948	0.033413588976387	1	1	0.898469719935923	0.999999169059752	0.29057016975577
down	NKX2-8; S100B; CCK; S100A6; MAP2; PTPRZ1; CNTN4; PARD3; SLITRK6;	GO:0007409~axonogenesis	9	78	11.5384615384615	0.00169207927494364	0.033413588976387	1	1	0.898494094995071	0.999999169059752	0.29057016975577
down	IL33; S100A8; S100A9; PLA2G2A; AGTR1; WNT5A; CX3CL1; IL18; NLRP10;	GO:0050729~positive regulation of inflammatory response	9	78	11.5384615384615	0.00169207927494364	0.033413588976387	1	1	0.898494094995071	0.999999169059752	0.29057016975577
up	IGHV4-39; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV3-43; TRDC; IGHV1-46; IGHV3-16; TRBC2; IGHV1-3; IGHV3-35; IGHV1-18; IGHV3-15; IGHV3-49; IGHV3-21; IGLC3; IGHE; IGHV3-23; IGHV3-13; IGHV3-7; IGHV2-5; IGHD; TRBC1; IGHV5-51; IGLC2; IGKC; IGHV6-1; IGHV4-34;	GO:0006910~phagocytosis, recognition	29	99	29.2929292929293	0.00191488858235189	0.51864757253001	1	1	0.999999410221451	0.99999941022145	1
down	CXCL14; CXCL10; IL18; SOSTDC1; CCL17;	GO:0045662~negative regulation of myoblast differentiation	5	24	20.8333333333333	0.00194773044359919	0.0377949774518063	1	1	0.929329066414426	0.999999169059752	0.328671458245559
down	PLA2G2A; BDKRB2; PLA2G4F; PLA2G3; ANXA1;	GO:0050482~arachidonic acid secretion	5	24	20.8333333333333	0.00194773044359919	0.0377949774518063	1	1	0.929329066414426	0.999999169059752	0.328671458245559
down	NKX2-8; FGF1; GLI2; PTN; WNT5A; WNT7B; FOXF1; SIM2; STRA6;	GO:0030324~lung development	9	80	11.25	0.00198325429609525	0.0378283219999531	1	1	0.931648800148149	0.999999169059752	0.32896142802469
down	PIGR; BTC; GRB7; FAM83B; EPGN; FAM83A; GAREM1;	GO:0007173~epidermal growth factor receptor signaling pathway	7	50	14	0.00203031301040402	0.0385071230278321	1	1	0.93436941286773	0.999999169059752	0.334864395528138
down	SCNN1A; SCNN1B; SCNN1G; TFAP2B;	GO:0055078~sodium ion homeostasis	4	14	28.5714285714286	0.00210618503742099	0.0392803509479015	1	1	0.939186428462141	0.999999169059752	0.341588515111738
down	COBL; BMP7; PTN; VLDLR;	GO:1900006~positive regulation of dendrite development	4	14	28.5714285714286	0.00210618503742099	0.0392803509479015	1	1	0.939186428462141	0.999999169059752	0.341588515111738
down	GLI2; BMP2; FGFR3; HES5; WNT2B; CYTL1;	GO:0002062~chondrocyte differentiation	6	37	16.2162162162162	0.00217490699379708	0.0396103437835183	1	1	0.943318988757614	0.999999169059752	0.344458188116068
down	AGR2; PTN; FOXF1; VWC2; EGFLAM; NPNT;	GO:0010811~positive regulation of cell-substrate adhesion	6	37	16.2162162162162	0.00217490699379708	0.0396103437835183	1	1	0.943318988757614	0.999999169059752	0.344458188116068
down	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.00227137128480293	0.0396103437835183	1	1	0.949261232319732	0.999999169059752	0.344458188116068
down	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.00227137128480293	0.0396103437835183	1	1	0.949261232319732	0.999999169059752	0.344458188116068
down	CYP2E1; CYP2C9; CYP2C19;	GO:0016098~monoterpenoid metabolic process	3	6	50	0.00227137128480293	0.0396103437835183	1	1	0.949261232319732	0.999999169059752	0.344458188116068
down	SERPINB7; LUM; CX3CL1;	GO:0032914~positive regulation of transforming growth factor beta1 production	3	6	50	0.00227137128480293	0.0396103437835183	1	1	0.949261232319732	0.999999169059752	0.344458188116068
down	CYP2E1; UGT1A1; CYP2C19;	GO:0046483~heterocycle metabolic process	3	6	50	0.00227137128480293	0.0396103437835183	1	1	0.949261232319732	0.999999169059752	0.344458188116068
down	ALOX15B; ALOX12B; ALOXE3;	GO:0051122~hepoxilin biosynthetic process	3	6	50	0.00227137128480293	0.0396103437835183	1	1	0.949261232319732	0.999999169059752	0.344458188116068
down	JUP; DSP; DSC2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	3	6	50	0.00227137128480293	0.0396103437835183	1	1	0.949261232319732	0.999999169059752	0.344458188116068
down	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.00227137128480293	0.0396103437835183	1	1	0.949261232319732	0.999999169059752	0.344458188116068
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.00227137128480293	0.0396103437835183	1	1	0.949261232319732	0.999999169059752	0.344458188116068
down	IRF6; WNT9B; TCF21; GABRB3; MEOX2; DLX5; FOXF2; INTU;	GO:0060021~roof of mouth development	8	66	12.1212121212121	0.0022771561168381	0.0396103437835183	1	1	0.949574100721487	0.999999169059752	0.344458188116068
down	CTSV; GJA1; PTN; GJB2; STC1;	GO:0046697~decidualization	5	25	20	0.00227727028603486	0.0396103437835183	1	1	0.949621709276537	0.999999169059752	0.344458188116068
down	ANXA2P2; SCGB1A1; NQO1; UGT1A1; SERPINB3; UGT1A7; UGT1A8;	GO:0043086~negative regulation of catalytic activity	7	52	13.4615384615385	0.0024813863900055	0.0427180210833255	1	1	0.961970273883206	0.999999169059752	0.371483070752569
down	ZBTB7C; BMP2; SULT1E1; KLF5; MEDAG; CDS1; RARRES2;	GO:0045600~positive regulation of fat cell differentiation	7	52	13.4615384615385	0.0024813863900055	0.0427180210833255	1	1	0.961970273883206	0.999999169059752	0.371483070752569
up	HLA-B; HLA-H; HLA-A; HLA-C; HLA-E; HLA-F; B2M;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	7	9	77.7777777777778	0.00248406158686554	0.640769600764315	1	1	0.999999410221451	0.99999941022145	1
down	CTSV; NRTN; NTF4; NTF3;	GO:0021675~nerve development	4	15	26.6666666666667	0.00260178850353177	0.0441121414462431	1	1	0.969241312085387	0.999999169059752	0.383606575078885
down	ADCYAP1; ADCYAP1R1; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	4	15	26.6666666666667	0.00260178850353177	0.0441121414462431	1	1	0.969241312085387	0.999999169059752	0.383606575078885
down	PLA2G4D; GDPD3; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	4	15	26.6666666666667	0.00260178850353177	0.0441121414462431	1	1	0.969241312085387	0.999999169059752	0.383606575078885
down	PLA2G2A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	5	26	19.2307692307692	0.00264555887981255	0.0446288500478931	1	1	0.971066285129626	0.999999169059752	0.388099959677642
down	NFASC; MAL; KEL; ADGRG6; KLK6; MAL2; MALL;	GO:0042552~myelination	7	53	13.2075471698113	0.00273396231584988	0.0457845514809081	1	1	0.973924272858436	0.999999169059752	0.398150133031228
down	MT1A; MT1E; MT1G; MT1H; MT1X; MT1M;	GO:0071276~cellular response to cadmium ion	6	39	15.3846153846154	0.00275498343733793	0.0457845514809081	1	1	0.974737613239757	0.999999169059752	0.398150133031228
down	WNT9B; GJB3; AQP1; WNT5A; WNT7B; PTK6; FZD10; BRINP1;	GO:0071300~cellular response to retinoic acid	8	69	11.5942028985507	0.00292749560132644	0.0483990265103058	1	1	0.980262780296588	0.999999169059752	0.420886046065028
down	GLI2; HOXD10; HOXC10; HOXD9; HOXC9;	GO:0009954~proximal/distal pattern formation	5	27	18.5185185185185	0.00305511970092498	0.0483990265103058	1	1	0.984124101603803	0.999999169059752	0.420886046065028
down	ADCYAP1; ADCYAP1R1; DEFB1; ADGRG6; PCLO;	GO:0019933~cAMP-mediated signaling	5	27	18.5185185185185	0.00305511970092498	0.0483990265103058	1	1	0.984124101603803	0.999999169059752	0.420886046065028
down	PLA2G2A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	5	27	18.5185185185185	0.00305511970092498	0.0483990265103058	1	1	0.984124101603803	0.999999169059752	0.420886046065028
down	CTNND1; PLEKHA7; CDH19; CDH17; CDH8;	GO:0044331~cell-cell adhesion mediated by cadherin	5	27	18.5185185185185	0.00305511970092498	0.0483990265103058	1	1	0.984124101603803	0.999999169059752	0.420886046065028
down	TULP1; PIGR; TF; HSPB1; AZGP1; ZG16B;	GO:0001895~retina homeostasis	6	40	15	0.00308503303422669	0.0483990265103058	1	1	0.985139709551795	0.999999169059752	0.420886046065028
down	S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	CYP1A1; TH; LCN2;	GO:0009635~response to herbicide	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	AQP1; AQP2; AQP3;	GO:0015793~glycerol transport	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	IDO1; ADCYAP1R1; LRP11;	GO:0033555~multicellular organismal response to stress	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	IL33; CX3CL1; IL34;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	AQP1; RHCG; RHBG;	GO:0072488~ammonium transmembrane transport	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	ANXA8; SPINK6; SPINK5;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	CCK; GJA1; NPAS2;	GO:2000987~positive regulation of behavioral fear response	3	7	42.8571428571429	0.00316903404230939	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	CXCL10; BMP7; STC1; AQP3;	GO:0033280~response to vitamin D	4	16	25	0.00317181585709481	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
down	GLI2; FOXF2; RARRES2; STRA6;	GO:0048566~embryonic digestive tract development	4	16	25	0.00317181585709481	0.0483990265103058	1	1	0.987435737527121	0.999999169059752	0.420886046065028
up	CD74; CD19; CD27; PRKCD; TCIRG1; INPP5D; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	8	13	61.5384615384615	0.00348279671744312	0.857559537199516	1	1	0.999999410221451	0.99999941022145	1
down	S100A8; S100A9; CTSG; NLRP10; RNASE7;	GO:0050832~defense response to fungus	5	28	17.8571428571429	0.00350847879682736	0.0530538888331057	1	1	0.995989408157121	0.999999169059752	0.461365508965035
down	NFASC; PIGR; SLPI; CSTB; S100A8; S100A9; CTSG; MIF; JUP; DSP; TCN1; SERPINB3; CHRNB4; S100A7; S100A11; PRSS3; CEACAM6; CRISP3; LCN2; FABP5; DSG1; PLD1; PKP1; FLG2; HRNR; GGH; SERPINB12; CALML5;	GO:0043312~neutrophil degranulation	28	483	5.79710144927536	0.00369013393376005	0.0555505812360202	1	1	0.999999169059752	0.999999169059752	0.483077164538924
down	KRT6A; KRT16; SERPINB5; CA9;	GO:0002009~morphogenesis of an epithelium	4	17	23.5294117647059	0.00382135344553003	0.0564277978473991	1	1	0.999999169059752	0.999999169059752	0.490705587210343
down	AQP1; AQP2; AQP5; AQP3;	GO:0006833~water transport	4	17	23.5294117647059	0.00382135344553003	0.0564277978473991	1	1	0.999999169059752	0.999999169059752	0.490705587210343
down	ALOX15B; PLA2G2A; AGTR1; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	4	17	23.5294117647059	0.00382135344553003	0.0564277978473991	1	1	0.999999169059752	0.999999169059752	0.490705587210343
down	CTSV; AQP3; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	4	17	23.5294117647059	0.00382135344553003	0.0564277978473991	1	1	0.999999169059752	0.999999169059752	0.490705587210343
down	FOXP2; CYP1A1; HES5; GRHL2; PITX2; STRA6;	GO:0043010~camera-type eye development	6	42	14.2857142857143	0.00383245097086893	0.0564277978473991	1	1	0.999999169059752	0.999999169059752	0.490705587210343
down	DLX3; GLI2; BMP2; BMP7; AMTN; SOSTDC1; NKX2-3;	GO:0042475~odontogenesis of dentin-containing tooth	7	57	12.280701754386	0.00394616859320851	0.0577484189126935	1	1	0.999999169059752	0.999999169059752	0.502189929326265
up	FCER1G; AIF1; IGHG2; IGHV1-2; IGHV3-30; IGHE; IGLC2; IGHV3-7; IGHV3-43; IGHV3-21; IGHV2-5; TRDC; TRBC2; IGHV3-16; IGHV4-39; IGHV3-49; IGHV1-3; IGHV1-46; IGHV3-15; IGHV6-1; IGHV3-13; IGHV3-35; IGKC; IGHV4-34; IGLC3; IGHV5-51; IGHV1-18; IGHD; IGLL5; TRBC1; IGHV3-23;	GO:0006911~phagocytosis, engulfment	31	115	26.9565217391304	0.00395302628705596	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	BMP7; ITGA8; IRX3; SOX17; ROBO2;	GO:0001656~metanephros development	5	29	17.2413793103448	0.00400815657034781	0.0577484189126935	1	1	0.999999169059752	0.999999169059752	0.502189929326265
down	PHGDH; EPHA2; HES5; INTU; GRHL2;	GO:0021915~neural tube development	5	29	17.2413793103448	0.00400815657034781	0.0577484189126935	1	1	0.999999169059752	0.999999169059752	0.502189929326265
down	ADRA2C; EDNRB; FABP5; MGLL; TMEM100;	GO:0051930~regulation of sensory perception of pain	5	29	17.2413793103448	0.00400815657034781	0.0577484189126935	1	1	0.999999169059752	0.999999169059752	0.502189929326265
down	ABO; FUT1; FUT3; FUT6; FUT2; ST6GAL2; B3GNT6; B3GNT3; B3GALT5;	GO:0006486~protein glycosylation	9	90	10	0.00409071212837619	0.0586859855340123	1	1	0.999999169059752	0.999999169059752	0.510343165798602
down	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.00425582452238715	0.0592813399238742	1	1	0.999999169059752	0.999999169059752	0.515520467352447
down	HOXD9; HOXD10; TFAP2B;	GO:0035137~hindlimb morphogenesis	3	8	37.5	0.00425582452238715	0.0592813399238742	1	1	0.999999169059752	0.999999169059752	0.515520467352447
down	DLG2; MAGI3; TJP2;	GO:0046710~GDP metabolic process	3	8	37.5	0.00425582452238715	0.0592813399238742	1	1	0.999999169059752	0.999999169059752	0.515520467352447
down	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.00425582452238715	0.0592813399238742	1	1	0.999999169059752	0.999999169059752	0.515520467352447
down	CRABP2; EFNA5; LPAR3;	GO:0048672~positive regulation of collateral sprouting	3	8	37.5	0.00425582452238715	0.0592813399238742	1	1	0.999999169059752	0.999999169059752	0.515520467352447
down	CYP1A1; MAOB; DUOX2;	GO:0050665~hydrogen peroxide biosynthetic process	3	8	37.5	0.00425582452238715	0.0592813399238742	1	1	0.999999169059752	0.999999169059752	0.515520467352447
down	COBL; PLS3; PLS1;	GO:0051639~actin filament network formation	3	8	37.5	0.00425582452238715	0.0592813399238742	1	1	0.999999169059752	0.999999169059752	0.515520467352447
down	BMP7; HOXD3; WNT5A; LUM; PITX1; HES5; IL17F;	GO:0051216~cartilage development	7	58	12.0689655172414	0.00430445946123903	0.0597110347577662	1	1	0.999999169059752	0.999999169059752	0.519257165643536
down	CXCL14; EPHA2; AGTR1; CX3CL1; ARHGEF16; SAA2; SAA1; DEFB4A;	GO:0060326~cell chemotaxis	8	74	10.8108108108108	0.0043228194412015	0.05971895005808	1	1	0.999999169059752	0.999999169059752	0.519325998421644
down	PLA2G2A; PLA2G4F; PLA2G4D; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	4	18	22.2222222222222	0.00455532354952426	0.062163500633142	1	1	0.999999169059752	0.999999169059752	0.540584219921715
down	CXCL10; S100A7; CXCL17; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	4	18	22.2222222222222	0.00455532354952426	0.062163500633142	1	1	0.999999169059752	0.999999169059752	0.540584219921715
down	CLEC3B; BMP2; PTN; FGFR3; GPNMB; TUFT1;	GO:0030282~bone mineralization	6	44	13.6363636363636	0.00470615083419856	0.0639617342121643	1	1	0.999999169059752	0.999999169059752	0.556221960503437
down	EPHA2; APLNR; SOX18; KDR; FOXF1; SOX17; TMEM100;	GO:0001570~vasculogenesis	7	60	11.6666666666667	0.00509413696550431	0.0684040711727919	1	1	0.999999169059752	0.999999169059752	0.594853267235381
down	BMP2; BMP7; NPPC; WNT4; WNT7B; FFAR4; NPNT;	GO:0045669~positive regulation of osteoblast differentiation	7	60	11.6666666666667	0.00509413696550431	0.0684040711727919	1	1	0.999999169059752	0.999999169059752	0.594853267235381
down	ALOX12B; CERS3; SPTSSB; ALOXE3; DEGS2;	GO:0046513~ceramide biosynthetic process	5	31	16.1290322580645	0.00515647423633436	0.0686916032197399	1	1	0.999999169059752	0.999999169059752	0.597353694105147
down	DKK1; PAX9; DLX5; STRA6; CRISPLD1;	GO:0060325~face morphogenesis	5	31	16.1290322580645	0.00515647423633436	0.0686916032197399	1	1	0.999999169059752	0.999999169059752	0.597353694105147
down	PLA2G2A; PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	4	19	21.0526315789474	0.00537846508707851	0.0703598258301349	1	1	0.999999169059752	0.999999169059752	0.611860837514239
down	FUT1; FUT6; FUT2;	GO:0042355~L-fucose catabolic process	3	9	33.3333333333333	0.00554234996979641	0.0703598258301349	1	1	0.999999169059752	0.999999169059752	0.611860837514239
down	SOX18; ID1; EMP2;	GO:0043534~blood vessel endothelial cell migration	3	9	33.3333333333333	0.00554234996979641	0.0703598258301349	1	1	0.999999169059752	0.999999169059752	0.611860837514239
down	AKR1B10; AKR1C2; AKR1C1;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.00554234996979641	0.0703598258301349	1	1	0.999999169059752	0.999999169059752	0.611860837514239
down	AKR1B10; AKR1C2; AKR1C1;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.00554234996979641	0.0703598258301349	1	1	0.999999169059752	0.999999169059752	0.611860837514239
down	ELN; NPPC; PDE1A;	GO:0048660~regulation of smooth muscle cell proliferation	3	9	33.3333333333333	0.00554234996979641	0.0703598258301349	1	1	0.999999169059752	0.999999169059752	0.611860837514239
down	AGTR1; APLNR; FGFBP1;	GO:1903589~positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis	3	9	33.3333333333333	0.00554234996979641	0.0703598258301349	1	1	0.999999169059752	0.999999169059752	0.611860837514239
up	SPI1; TGFBR2; RELB; RBPJ; DHRS2; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	9	18	50	0.00555183114134983	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	EFNA1; EPHA2; ID1; EMP2; GPNMB;	GO:0045765~regulation of angiogenesis	5	32	15.625	0.00581005683991886	0.0714445450974638	1	1	0.999999169059752	0.999999169059752	0.621293738058621
down	CHRNB4; SLC1A3; CLDN10; SLC5A12; SLC26A9; SLC5A8; WNK4; SLC25A10; STEAP1;	GO:0006811~ion transport	9	96	9.375	0.00601436128245691	0.0734189484553013	1	1	0.999999169059752	0.999999169059752	0.638463480562446
down	CLDN1; NOS2; WNT5A; GBP6; RAB7B; CX3CL1; CCL17; CCL19; CCL11;	GO:0071346~cellular response to interferon-gamma	9	96	9.375	0.00601436128245691	0.0734189484553013	1	1	0.999999169059752	0.999999169059752	0.638463480562446
up	CXCR1; CXCR5; CCR2; CCR10; CXCR3; CCR5; CCR6; CCR8; GPR35; CCL26; CCL2; CCL21; PPBP; CCL24; CXCL3; XCL2; CCL8; XCL1; CCL7; PF4V1; PF4;	GO:0070098~chemokine-mediated signaling pathway	21	70	30	0.00601752688813184	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	DEFB4A; CXCL14; C1QC; SLPI; HLA-DQB2; CD1A; CTSG; CD1E; ENDOU; DEFB1; CX3CL1; MS4A2; GBP6; CCL19; IL36B; IL36A; CXCL10; RAET1G; IGLV3-9; RAET1L; AZGP1; CXCL9; CD1B; RAET1E; CXCL11;	GO:0006955~immune response	25	433	5.77367205542725	0.00610941409921284	0.0743090693154257	1	1	0.999999169059752	0.999999169059752	0.646204120743669
down	TFF1; TH; GJA1; BMP7; GNAI1; ANXA1;	GO:0043434~response to peptide hormone	6	47	12.7659574468085	0.00627952665202847	0.0752077551635687	1	1	0.999999169059752	0.999999169059752	0.654019243496168
down	FGF1; PTN; BTC; MACC1; GAREM1; GKN1;	GO:0051781~positive regulation of cell division	6	47	12.7659574468085	0.00627952665202847	0.0752077551635687	1	1	0.999999169059752	0.999999169059752	0.654019243496168
down	CYP1A1; CYP2C9; UGT1A1; SULT1E1;	GO:0008210~estrogen metabolic process	4	20	20	0.00629531700952124	0.0752077551635687	1	1	0.999999169059752	0.999999169059752	0.654019243496168
down	EDN3; EDN2; HRC; NMU;	GO:0010460~positive regulation of heart rate	4	20	20	0.00629531700952124	0.0752077551635687	1	1	0.999999169059752	0.999999169059752	0.654019243496168
down	FOXH1; FOLR1; SOX18; WNT5A; OVOL2; SOX17; NDRG4;	GO:0001947~heart looping	7	63	11.1111111111111	0.00647624211585762	0.0765282057544268	1	1	0.999999169059752	0.999999169059752	0.665502103137822
down	SPTBN2; ADGRF1; SLITRK6; PCDHB10; PCDHB5; PCDHB11; PCLO;	GO:0007416~synapse assembly	7	63	11.1111111111111	0.00647624211585762	0.0765282057544268	1	1	0.999999169059752	0.999999169059752	0.665502103137822
down	ERBB3; TYRO3; NYAP1; PREX2; PIK3C2G;	GO:0014065~phosphatidylinositol 3-kinase signaling	5	33	15.1515151515152	0.00651982926594163	0.0765282057544268	1	1	0.999999169059752	0.999999169059752	0.665502103137822
down	SAA1; CX3CL1; CCL19; CCL17; CCL11;	GO:0048247~lymphocyte chemotaxis	5	33	15.1515151515152	0.00651982926594163	0.0765282057544268	1	1	0.999999169059752	0.999999169059752	0.665502103137822
down	TCF21; CDKN2B; CDH17; NKX2-3; PITX2;	GO:0048536~spleen development	5	33	15.1515151515152	0.00651982926594163	0.0765282057544268	1	1	0.999999169059752	0.999999169059752	0.665502103137822
up	TNF; APOA2; CD74; ELANE; RELA; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	8	15	53.3333333333333	0.00660386466589558	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	SORBS2; MSMB; TM4SF1; CRYBA2; KRTDAP; TCHH; RAD51AP2; KRT24; PRICKLE4; TTC39A; GGT6; SBSN; IGFL2; KRT27; TMPRSS11B; UNC93A; IL22RA1; FIBIN; NKX2-3; GIPC2; TMEM54; TMEM125; GPR87; GSDMC; GCOM2; UACA; RNF39; CCM2L; ETNK2; CGN; PSORS1C2; LINC01558;	GO:0008150~biological_process	32	603	5.30679933665008	0.00689419205426556	0.0803604261325329	1	1	0.999999169059752	0.999999169059752	0.698827733814452
down	EMP1; EMP2; LPAR3;	GO:0032060~bleb assembly	3	10	30	0.00703762741128899	0.0809086137660861	1	1	0.999999169059752	0.999999169059752	0.703594865350431
down	DLG2; MAGI3; TJP2;	GO:0046037~GMP metabolic process	3	10	30	0.00703762741128899	0.0809086137660861	1	1	0.999999169059752	0.999999169059752	0.703594865350431
down	CYP1A1; CYP2C9; CYP2C19;	GO:0097267~omega-hydroxylase P450 pathway	3	10	30	0.00703762741128899	0.0809086137660861	1	1	0.999999169059752	0.999999169059752	0.703594865350431
down	PSCA; SLURP1; LYPD6;	GO:0099601~regulation of neurotransmitter receptor activity	3	10	30	0.00703762741128899	0.0809086137660861	1	1	0.999999169059752	0.999999169059752	0.703594865350431
down	PLA2G2A; PLD1; LIPK; LIPI; ASPG; PLA2G3; PNLIPRP3; CES3;	GO:0016042~lipid catabolic process	8	81	9.87654320987654	0.00707283255310609	0.0810358323576012	1	1	0.999999169059752	0.999999169059752	0.7047011795437
down	AQP1; AQP2; TFAP2B; AQP3; MYO5B;	GO:0003091~renal water homeostasis	5	34	14.7058823529412	0.0072881710165269	0.082906606216486	1	1	0.999999169059752	0.999999169059752	0.720969742556639
down	PLA2G2A; PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036150~phosphatidylserine acyl-chain remodeling	4	21	19.047619047619	0.00731020418232942	0.082906606216486	1	1	0.999999169059752	0.999999169059752	0.720969742556639
down	CLDN1; TJP1; OCLN; MARVELD2;	GO:0045216~cell-cell junction organization	4	21	19.047619047619	0.00731020418232942	0.082906606216486	1	1	0.999999169059752	0.999999169059752	0.720969742556639
down	C2CD4B; PRLR; FUT1; FUT2; IL18; SPINK5;	GO:0030155~regulation of cell adhesion	6	49	12.2448979591837	0.0075209973603575	0.084441431902074	1	1	0.999999169059752	0.999999169059752	0.734316843950685
down	KLK8; SNCG; NFASC; C1QA; WNT7B; PCDHGC4;	GO:0050808~synapse organization	6	49	12.2448979591837	0.0075209973603575	0.084441431902074	1	1	0.999999169059752	0.999999169059752	0.734316843950685
down	CHP2; RASAL1; WNT5A; PRKAA2; HPCA; ACER1; ADGRV1; SYT8;	GO:0071277~cellular response to calcium ion	8	82	9.75609756097561	0.00755378106306137	0.0845268100956567	1	1	0.999999169059752	0.999999169059752	0.73505930703121
up	HLA-E; HLA-F; HLA-C; HLA-A; HLA-B; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	7	12	58.3333333333333	0.00767558083355069	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	HLA-B; HLA-A; HLA-C; HLA-H; FCGRT; HLA-F; HLA-E;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	7	12	58.3333333333333	0.00767558083355069	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	TRPM2; LYN; GATA1; AXL; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	7	12	58.3333333333333	0.00767558083355069	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	KLK8; BRINP1; CIDEA; EMP1; EMP2;	GO:0008219~cell death	5	35	14.2857142857143	0.00811741322545734	0.0905320803915624	1	1	0.999999169059752	0.999999169059752	0.787282143989662
down	CIDEA; EDN2; ACADL; NMU;	GO:0001659~temperature homeostasis	4	22	18.1818181818182	0.00842722555430209	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
down	TFF1; CYP1A1; TH; LRP11;	GO:0035902~response to immobilization stress	4	22	18.1818181818182	0.00842722555430209	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
down	CSTA; CSTB; SERPINB3; CAMK2N1;	GO:0045861~negative regulation of proteolysis	4	22	18.1818181818182	0.00842722555430209	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
down	S100A8; S100A9; CX3CL1;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.00874919627577375	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
down	RAMP3; MIF; ADGRV1;	GO:0010739~positive regulation of protein kinase A signaling	3	11	27.2727272727273	0.00874919627577375	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
down	IRF6; KLK8; SDR16C5;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.00874919627577375	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
down	DSP; PLEKHA7; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	3	11	27.2727272727273	0.00874919627577375	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
down	JUP; DSP; DSC2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	3	11	27.2727272727273	0.00874919627577375	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
down	WNT5A; FOXA1; TJP1;	GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin	3	11	27.2727272727273	0.00874919627577375	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
up	TYROBP; CTLA4; IL10; MNDA; INPP5D; CD300A; LYN; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	8	16	50	0.00879106753489356	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	CXCL10; EDN3; ELN; BDKRB2; MEOX2;	GO:0008015~blood circulation	5	36	13.8888888888889	0.00900983276289979	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
down	CXCL10; HSPA2; CDH8; LRP11; ACOT11;	GO:0009409~response to cold	5	36	13.8888888888889	0.00900983276289979	0.0915295618089229	1	1	0.999999169059752	0.999999169059752	0.795956409569917
up	OR2A1; GPR25; GPR31; P2RY10; CCL21; FCN1; GPR171; GNB5; RGS13; GNRH2; RGS10; LGR5; RGS9; OR6A2; UTS2; ADCY5; OR2H2; S1PR4; F2; KNG1; OXT; TSHB; CALCA; PTH; GHRH; PPBP; PF4; OPN1SW; GNAI2; PSAP; RHOC; SCT; OR2T7; ADORA3; CALM2; CALM3; CALCB; RAC2; GNB3; CXCL3; TRH; TBXA2R; HRH2; CXCR1; FPR3; ADRA1D; EDNRA; F2R; PDE4A; HTR2A; PTPN6; AVPR2; AKT1; CCR7; GPR183; CXCR5; SSTR3; CNR2; TRHR; OPRM1; PTGER4; DRD3; GRK3; OPRD1; RGS2; VIPR2; CCR2; PTGIR; GLP1R; GRK6; CCR10; XCL1; CXCR3; GPR15; RGS19; RGS3; HTR6; CCR5; CCR6; CCR8; ADCY7; NLRP6; TAS2R38; TAS2R39; TAS2R40; TAS2R41; TAS2R50; GNA12; APLP2; RGS1; PTGDR; ADGRE1; GPR18; FZD2; GPR68; OR2B11; FGD3; PIK3R6; OR2T2; TAS2R42; OR2W3; VN1R5; FGD2; GPR65; OR2L13; OR2C3; PROKR2; OR2L5; OR2AK2; OR2L3; OR10G2; OR10AD1; OR52B6; OR2D3; OR56B2P; OR52N4; OR56B1; OR52H1; OR52K1; OR52I1; OR9A1P; OR9A4; GPR150; OR13D1; OR2T34; OR2L8; OR2AJ1; OR2T10; OR2T3; OR10AC1; OR2L2; OR52N5; OR52P1P; OR52I2; OR2AE1; GPBAR1; RXFP4; GPR151; RXFP2; RLN3; PIK3R5; KISS1R; GPR146; NPY6R; GPR21; P2RY13; INPP5K; ADGRE3; OR2B2; GPR88; NPFFR1; OR2AG1; OR10A5; OR10A2; OR10A4; OR2D2; CXCL16; OR51M1; OR51I1; OR51I2; OR52D1; PLEKHG2; NMUR1; PROK2; GPR35; CYSLTR2; TAS2R13; TAS2R10; XCL2; GPR160; GNG8; GPR132; GPR55; PTGDR2; OR4D1; GPR34; CCL8; OR4E2; OR1L3; OR1A1; GNG11; GNG7; OR7C1; OR1F1; OR1F2P; OR1L8; OR4E1; OR3A3; CCL26; OR5C1; GPR152; CCL2; OR3A1; MRGPRD; GNG10; OR5K2; OR3A4P; OR1F12; OR1J1; OR1Q1; OR1L4; OR5B21; CCL7; CCL24; OR5K1; OR1L6; OR5B2;	GO:0007186~G protein-coupled receptor signaling pathway	207	1152	17.96875	0.00955747528900019	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	PTN; PTPRZ1; ASPA; IL34;	GO:0048714~positive regulation of oligodendrocyte differentiation	4	23	17.3913043478261	0.0096502444314418	0.0939010740763772	1	1	0.999999169059752	0.999999169059752	0.816579477706029
down	RHOD; EFNA5; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	4	23	17.3913043478261	0.0096502444314418	0.0939010740763772	1	1	0.999999169059752	0.999999169059752	0.816579477706029
down	ANXA1; ADCYAP1; UGT1A1; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	4	23	17.3913043478261	0.0096502444314418	0.0939010740763772	1	1	0.999999169059752	0.999999169059752	0.816579477706029
down	TCF21; EPCAM; BMP7; NPNT; ROBO2;	GO:0001657~ureteric bud development	5	37	13.5135135135135	0.00996764670870864	0.0964305187352591	1	1	0.999999169059752	0.999999169059752	0.838575952386991
down	FOXN1; DKK1; HOXC13; SOX18; DSG4;	GO:0001942~hair follicle development	5	37	13.5135135135135	0.00996764670870864	0.0964305187352591	1	1	0.999999169059752	0.999999169059752	0.838575952386991
down	PARD3; PARD6G; CAP2; RHOD; RND3; RHOV;	GO:0007163~establishment or maintenance of cell polarity	6	53	11.3207547169811	0.0105186993992405	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	ADCYAP1; EDNRB; BDKRB1; NMU; DLG2; ALOXE3;	GO:0019233~sensory perception of pain	6	53	11.3207547169811	0.0105186993992405	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	IL33; ADCYAP1; WNT5A; RAB7B; IL1RL2; IL36A;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.0105186993992405	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
up	IRGM; HP; PPBP; ELANE; CEBPB; TNFRSF1A; BCL3; IL10; IRF8; PRKCD; RBPJ; CEBPE; DEFB108B; MYD88; AICDA; TLR9; IGHV6-1; IGHG2; IGLC3; IGHV1-46; IGHV3-13; TRBC1; IGHV1-2; TRBC2; IGHV3-30; IGLC2; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV1-18; IGHV3-7; IGHE; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-35; IGHV3-23; FCER1G; HAMP; TRDC; IGHV3-43; IGKC; IGHV4-39; IGHV3-21; GSDMD; IGHV3-16; IGHV1-3;	GO:0042742~defense response to bacterium	48	216	22.2222222222222	0.0105677079564032	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	DKK1; SOX7; SOX17;	GO:0001706~endoderm formation	3	12	25	0.0106832247812585	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	EDN3; EDN2; PTN;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.0106832247812585	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	ADH7; ALDH3B2; SULT1E1;	GO:0006068~ethanol catabolic process	3	12	25	0.0106832247812585	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	ADH1B; ADH1C; ADH7;	GO:0006069~ethanol oxidation	3	12	25	0.0106832247812585	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	EDNRB; ATP6V0A4; RHCG;	GO:0006885~regulation of pH	3	12	25	0.0106832247812585	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	CHST9; DIO2; DUOX2;	GO:0042446~hormone biosynthetic process	3	12	25	0.0106832247812585	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	BMP2; PTN; WNT5A;	GO:0045778~positive regulation of ossification	3	12	25	0.0106832247812585	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	EDN3; EDN2; GPR62;	GO:0048016~inositol phosphate-mediated signaling	3	12	25	0.0106832247812585	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	GABRB3; WNT5A; GABRB2;	GO:1904862~inhibitory synapse assembly	3	12	25	0.0106832247812585	0.0996210710852354	1	1	0.999999169059752	0.999999169059752	0.866321530349372
down	SHROOM3; NOX4; TFCP2L1; CDH17; CDH8; CDH19; CAP2; NCKAP1;	GO:0000902~cell morphogenesis	8	88	9.09090909090909	0.0109726279424176	0.100554564474269	1	1	0.999999169059752	0.999999169059752	0.87443934531109
down	EFNA1; FOXA1; VASN; OVOL2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	4	24	16.6666666666667	0.0109828806837015	0.100554564474269	1	1	0.999999169059752	0.999999169059752	0.87443934531109
down	CX3CL1; CXCL10; CXCL11; CXCL9;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.0109828806837015	0.100554564474269	1	1	0.999999169059752	0.999999169059752	0.87443934531109
down	CYP1A1; GJB2; ID1; SLC1A3;	GO:0046677~response to antibiotic	4	24	16.6666666666667	0.0109828806837015	0.100554564474269	1	1	0.999999169059752	0.999999169059752	0.87443934531109
down	GLI2; WNT5A; MYO3A; GRHL3;	GO:0090103~cochlea morphogenesis	4	24	16.6666666666667	0.0109828806837015	0.100554564474269	1	1	0.999999169059752	0.999999169059752	0.87443934531109
down	TF; WNT5A; WNT7B; ERN2; CCL19;	GO:0007257~activation of JUN kinase activity	5	38	13.1578947368421	0.0109930071975146	0.100554564474269	1	1	0.999999169059752	0.999999169059752	0.87443934531109
down	CACNA1G; JUP; DSP; KCNJ5; DSC2;	GO:0086091~regulation of heart rate by cardiac conduction	5	38	13.1578947368421	0.0109930071975146	0.100554564474269	1	1	0.999999169059752	0.999999169059752	0.87443934531109
down	SASH1; FGF1; FUT1; KDR; WNT5A; ATOH8;	GO:0010595~positive regulation of endothelial cell migration	6	54	11.1111111111111	0.011383670186354	0.103845056564104	1	1	0.999999169059752	0.999999169059752	0.903054016000889
up	CCL21; TRPM2; CXCR1; CCR7; GPR183; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	8	17	47.0588235294118	0.0114765158810641	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	IRGM; ACOD1; CD14; VIM; CSF3; TFPI; CCL2; CEBPB; TNFRSF1B; TBXA2R; IL10; CASP1; AXL; CCR5; HAMP; IRF8; RELA; CEBPE; CARD16; LILRB2; TNIP2; LILRB1; NLRP7; LITAF; MYD88; AICDA; PYCARD; DEFA4; PF4; PDCD1LG2; PF4V1; CD80; NR1H2; NR1I2; CXCL3; DEFA3; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	38	163	23.3128834355828	0.0115752842877478	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	CXCL10; PTN; EPHA2; EFNA3; ECSCR; IL17F; SPINK5; PLK2;	GO:0016525~negative regulation of angiogenesis	8	89	8.98876404494382	0.0116380351841919	0.105877734724478	1	1	0.999999169059752	0.999999169059752	0.920730525954249
down	DKK1; BMP7; HOXD10; DLX5; HOXC10;	GO:0030326~embryonic limb morphogenesis	5	39	12.8205128205128	0.0120879966352941	0.109378449338767	1	1	0.999999169059752	0.999999169059752	0.951173326949354
down	BMP2; BMP7; PTN; WNT4; ADGRV1;	GO:0030501~positive regulation of bone mineralization	5	39	12.8205128205128	0.0120879966352941	0.109378449338767	1	1	0.999999169059752	0.999999169059752	0.951173326949354
down	BMP2; WNT7B; WNT9B; WNT2B; WNT4; WNT5A;	GO:0045165~cell fate commitment	6	55	10.9090909090909	0.0122976210409281	0.110976112458053	1	1	0.999999169059752	0.999999169059752	0.965066873198207
down	SYCN; LGI3; SRCIN1; SYTL5; RAB25; EXOC3L4; CADPS2; STX19;	GO:0006887~exocytosis	8	90	8.88888888888889	0.012332668481694	0.110994016335246	1	1	0.999999169059752	0.999999169059752	0.965222568314913
down	NQO1; NOS2; SLC7A2;	GO:0006809~nitric oxide biosynthetic process	3	13	23.0769230769231	0.0128446103919284	0.11133956221944	1	1	0.999999169059752	0.999999169059752	0.968227493236317
down	ID1; CX3CL1; SYNPO2L;	GO:0032233~positive regulation of actin filament bundle assembly	3	13	23.0769230769231	0.0128446103919284	0.11133956221944	1	1	0.999999169059752	0.999999169059752	0.968227493236317
down	MMP12; WNT5A; TRIM6;	GO:0060340~positive regulation of type I interferon-mediated signaling pathway	3	13	23.0769230769231	0.0128446103919284	0.11133956221944	1	1	0.999999169059752	0.999999169059752	0.968227493236317
down	TCF21; ID1; WNT7B;	GO:0060425~lung morphogenesis	3	13	23.0769230769231	0.0128446103919284	0.11133956221944	1	1	0.999999169059752	0.999999169059752	0.968227493236317
down	CYP1A1; HNF4A; ANXA1;	GO:0070365~hepatocyte differentiation	3	13	23.0769230769231	0.0128446103919284	0.11133956221944	1	1	0.999999169059752	0.999999169059752	0.968227493236317
down	TULP1; PROM1; USH1G; ADGRV1; RDH12;	GO:0045494~photoreceptor cell maintenance	5	40	12.5	0.0132546232851216	0.11133956221944	1	1	0.999999169059752	0.999999169059752	0.968227493236317
down	CLDN1; CLEC3B; WNT5A; WNT4; OVOL2; NOX4;	GO:0071560~cellular response to transforming growth factor beta stimulus	6	56	10.7142857142857	0.0132618879606826	0.11133956221944	1	1	0.999999169059752	0.999999169059752	0.968227493236317
down	DKK1; CLDN7; CRYAB; ANXA1; HSPB1; CEACAM5; GLI2; MIF; NQO1; EPCAM; PRLR; EDNRB; AQP1; BTC; KDR; ID1; WNT5A; PRKAA2; CX3CL1; DHCR24; FFAR4; VTCN1; TFAP2B; CARD14; BCL2L10; PLK2;	GO:0043066~negative regulation of apoptotic process	26	489	5.31697341513292	0.0134855391786212	0.11133956221944	1	1	0.999999169059752	0.999999169059752	0.968227493236317
down	GJB3; GJB5; TRIP10; CCL19;	GO:0007154~cell communication	4	26	15.3846153846154	0.0139902330968427	0.113717221564409	1	1	0.999999169059752	0.999999169059752	0.988904017388726
up	HBD; HBQ1; HBG1; HBG2; HBA1; HBM; CYGB;	GO:0015671~oxygen transport	7	14	50	0.014007637984613	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	ZBTB7C; SULT2B1; IRF6; ALOX15B; GJB6; TFF1; BMP2; NPPC; AZGP1; S100A11; HNF4A; CDKN2B; SLURP1; DPT; FGFBP1; GPNMB; DHCR24; BNIPL; CAMK2N1; TFAP2B; SOX7; NOX4;	GO:0008285~negative regulation of cell population proliferation	22	396	5.55555555555556	0.0141931734438683	0.114810803014616	1	1	0.999999169059752	0.999999169059752	0.998413984960696
down	PPL; SCEL; IGFBP2; BDKRB1; LRP11; PIEZO2;	GO:0009612~response to mechanical stimulus	6	57	10.5263157894737	0.0142777775115701	0.115217545928704	1	1	0.999999169059752	0.999999169059752	1
down	CRYAB; WNT5A; WNT2B; SLITRK6; CRYBA2;	GO:0002088~lens development in camera-type eye	5	41	12.1951219512195	0.0144948172181127	0.116409333495705	1	1	0.999999169059752	0.999999169059752	1
down	SLC7A2; SLC38A3; SLC6A15; SLC6A14; SLC25A48;	GO:0006865~amino acid transport	5	41	12.1951219512195	0.0144948172181127	0.116409333495705	1	1	0.999999169059752	0.999999169059752	1
down	WNT5A; GRHL3; INTU;	GO:0001736~establishment of planar polarity	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	SFN; SLURP1; INTU;	GO:0010839~negative regulation of keratinocyte proliferation	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	ASPA; ID4; HES5;	GO:0022010~central nervous system myelination	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	EDNRB; BTC; TFAP2B;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	FOXA1; WNT4; KLK6;	GO:0042445~hormone metabolic process	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	AKR1C1; SDR16C5; BCO2;	GO:0042574~retinal metabolic process	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	FOXP2; ITGA8; STRA6;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	ADRA2A; MOGAT2; TJP2;	GO:0050892~intestinal absorption	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	SCNN1A; SCNN1B; SCNN1G;	GO:0050909~sensory perception of taste	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	CLDN1; TJP1; TJP2;	GO:0090557~establishment of endothelial intestinal barrier	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	RAMP3; MMP3; MMP12;	GO:1904645~response to amyloid-beta	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	GJA1; TJP1; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	3	14	21.4285714285714	0.0152370746351476	0.118955487326024	1	1	0.999999169059752	0.999999169059752	1
down	OVOL1; TCF21; GLI2; AGTR1; ITGA8; WNT4; TFAP2B; STRA6;	GO:0001822~kidney development	8	94	8.51063829787234	0.0154175406806867	0.120085113840058	1	1	0.999999169059752	0.999999169059752	1
down	JUP; FUT1; EMP2; CX3CL1;	GO:0001954~positive regulation of cell-matrix adhesion	4	27	14.8148148148148	0.0156709255734521	0.120382831007045	1	1	0.999999169059752	0.999999169059752	1
down	ALOX15B; ALOX12B; MGLL; ALOXE3;	GO:0019369~arachidonic acid metabolic process	4	27	14.8148148148148	0.0156709255734521	0.120382831007045	1	1	0.999999169059752	0.999999169059752	1
down	TJP1; WWC1; TJP2; AMOTL2;	GO:0035329~hippo signaling	4	27	14.8148148148148	0.0156709255734521	0.120382831007045	1	1	0.999999169059752	0.999999169059752	1
down	ANXA1; HSPB1; MT1G; KDR;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	4	27	14.8148148148148	0.0156709255734521	0.120382831007045	1	1	0.999999169059752	0.999999169059752	1
down	HNF4A; IL18; ANGPTL8; GPIHBP1;	GO:0070328~triglyceride homeostasis	4	27	14.8148148148148	0.0156709255734521	0.120382831007045	1	1	0.999999169059752	0.999999169059752	1
down	AGTR1; XDH; ACE2; NOX4;	GO:2000379~positive regulation of reactive oxygen species metabolic process	4	27	14.8148148148148	0.0156709255734521	0.120382831007045	1	1	0.999999169059752	0.999999169059752	1
down	WNT9B; TCF21; BMP2; WNT4; NPNT;	GO:0001658~branching involved in ureteric bud morphogenesis	5	42	11.9047619047619	0.015810426627101	0.120626368607223	1	1	0.999999169059752	0.999999169059752	1
down	CA12; AQP1; CA9; CYB5R2; SLC26A9;	GO:0015701~bicarbonate transport	5	42	11.9047619047619	0.015810426627101	0.120626368607223	1	1	0.999999169059752	0.999999169059752	1
down	DKK1; ADH7; LYPD6; GPIHBP1; DKK4;	GO:2000272~negative regulation of signaling receptor activity	5	42	11.9047619047619	0.015810426627101	0.120626368607223	1	1	0.999999169059752	0.999999169059752	1
down	GJA1; WNT5A; ID4; DUOXA1; DUOXA2; FRMD6;	GO:0034613~cellular protein localization	6	59	10.1694915254237	0.0164694905913777	0.124803792133758	1	1	0.999999169059752	0.999999169059752	1
down	BMP7; ID4; IRX3; HES5; CNTN4; NOTCH3;	GO:0045665~negative regulation of neuron differentiation	6	59	10.1694915254237	0.0164694905913777	0.124803792133758	1	1	0.999999169059752	0.999999169059752	1
down	TF; BMP2; BMP7; HNF4A; ATOH8; INHA;	GO:0060395~SMAD protein signal transduction	6	59	10.1694915254237	0.0164694905913777	0.124803792133758	1	1	0.999999169059752	0.999999169059752	1
up	PSMB11; TNFRSF13B; TNFSF12; TNFSF13; TNF; TNFRSF1A; TNFRSF1B; PSMA2; CD27; PSMB8; PSMB9; TNFRSF8; CD40LG; CD70; PSMB10; TNFRSF4; LIMS1; PSMB3; TNFRSF17; RELA; PSME1; TRADD; COMMD7; PSMA8; PSMF1; TNFRSF14; CDIP1; PYCARD; TNFRSF18;	GO:0033209~tumor necrosis factor-mediated signaling pathway	29	120	24.1666666666667	0.0171956654130486	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	MMP3; MMP7; COL15A1; MMP12; KLK6;	GO:0030574~collagen catabolic process	5	43	11.6279069767442	0.0172032144943464	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	COBL; CYP1A1; CLDN18; FOXF1;	GO:0048565~digestive tract development	4	28	14.2857142857143	0.0174731835552407	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	RAB38; ATP6V1C2; ATP6V0A4; SLAMF8;	GO:0090383~phagosome acidification	4	28	14.2857142857143	0.0174731835552407	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	NKX2-8; KRT4; PTN; WNT5A; CDKN2B; A4GNT;	GO:0050680~negative regulation of epithelial cell proliferation	6	60	10	0.0176477609162922	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	UNC13B; GJB6; TH; CMA1; PRKAA2; NOX4;	GO:0071333~cellular response to glucose stimulus	6	60	10	0.0176477609162922	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	GGT5; GGT6; CHAC1;	GO:0006750~glutathione biosynthetic process	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	SLC6A15; SLC6A14; GABRQ;	GO:0006836~neurotransmitter transport	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	SOX18; SOX17; NDRG4;	GO:0035050~embryonic heart tube development	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	TH; BMP7; FOXF2;	GO:0048596~embryonic camera-type eye morphogenesis	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	EDNRB; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	FOXA1; FOXF1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	BRINP1; SRPX2; MYH14;	GO:0071625~vocalization behavior	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	COBL; EPS8L1; EPS8L2;	GO:1900029~positive regulation of ruffle assembly	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	ID1; KLF5; KLF15;	GO:1901653~cellular response to peptide	3	15	20	0.0178632525546896	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
up	PPP1R11; PTGER4; BTN2A2; SYT11; FOXP3; RGCC; TNFRSF4;	GO:0050710~negative regulation of cytokine secretion	7	15	46.6666666666667	0.0182791672569478	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	TESPA1; RAB29; ADA; CCR7; RELA; TRAT1; PRKD2;	GO:0050862~positive regulation of T cell receptor signaling pathway	7	15	46.6666666666667	0.0182791672569478	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	CFAP69; OVOL1; CTSV; GJB3; GJA1; TSPAN8; KRT9; ADCYAP1R1; HSPA2; BNC1; TYRO3; WFDC2; ODF4; SHISA6; SPATA19; HORMAD1; FOXJ1; SOX17; BCL2L10; NPAP1; THEG; GGT5;	GO:0007283~spermatogenesis	22	407	5.40540540540541	0.0185105371515958	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	ANXA1; CX3CL1; CCL17; CCL19; CCL11;	GO:0002548~monocyte chemotaxis	5	44	11.3636363636364	0.0186748556070444	0.128869186146472	1	1	0.999999169059752	0.999999169059752	1
down	CD1B; AZGP1; CD1E; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	4	29	13.7931034482759	0.0193993497288477	0.132634657922081	1	1	0.999999169059752	0.999999169059752	1
down	IL33; SCGB1A1; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	4	29	13.7931034482759	0.0193993497288477	0.132634657922081	1	1	0.999999169059752	0.999999169059752	1
up	MS4A1; ORAI1; ORAI3; STIM2; ORAI2;	GO:0002115~store-operated calcium entry	5	8	62.5	0.0195506480064547	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	TNF; IFNG; IFNGR1; LRPAP1; MYOCD;	GO:1900222~negative regulation of amyloid-beta clearance	5	8	62.5	0.0195506480064547	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	TH; PTN; SLC6A1; ARC; STRA6; PAK5;	GO:0007612~learning	6	62	9.67741935483871	0.0201749672845271	0.137657246288938	1	1	0.999999169059752	0.999999169059752	1
down	RHOD; AIF1L; RND3; PLS3; PLS1;	GO:0051017~actin filament bundle assembly	5	45	11.1111111111111	0.0202269339151115	0.137731880634948	1	1	0.999999169059752	0.999999169059752	1
up	CCL24; CREB3; PLAU; RNASE2; CCL2; TYMP; FPR3; L1CAM; CCR6; NCKAP1L; CCL8; CCL7; CMTM8; CMTM2; CMTM5; CMTM7; CMTM3; CXCL16; PROK2; CCL26; PTGDR2; CXCR3; CCR10; CCR8; CXCR5; CXCR1; CCR7; CCR2; CCR5;	GO:0006935~chemotaxis	29	122	23.7704918032787	0.020375786565255	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	MIF; EDN2; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.0207247770642922	0.139146153209658	1	1	0.999999169059752	0.999999169059752	1
down	RAB25; GRHL2; POF1B;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.0207247770642922	0.139146153209658	1	1	0.999999169059752	0.999999169059752	1
down	AQP1; RHOD; RND3;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.0207247770642922	0.139146153209658	1	1	0.999999169059752	0.999999169059752	1
down	INHA; BMP7; CDKN2B;	GO:0042326~negative regulation of phosphorylation	3	16	18.75	0.0207247770642922	0.139146153209658	1	1	0.999999169059752	0.999999169059752	1
down	NOX5; NOX4; DUOX2;	GO:0042554~superoxide anion generation	3	16	18.75	0.0207247770642922	0.139146153209658	1	1	0.999999169059752	0.999999169059752	1
down	MMP7; PTN; ANXA1;	GO:0044849~estrous cycle	3	16	18.75	0.0207247770642922	0.139146153209658	1	1	0.999999169059752	0.999999169059752	1
down	WNT5A; KLK6; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	3	16	18.75	0.0207247770642922	0.139146153209658	1	1	0.999999169059752	0.999999169059752	1
up	SMAD7; HLA-F; XCL1; FOXP3;	GO:0002725~negative regulation of T cell cytokine production	4	5	80	0.0211030389736873	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	CAT; EPB42; ADD1; AHSP;	GO:0020027~hemoglobin metabolic process	4	5	80	0.0211030389736873	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	CNR2; MILR1; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	4	5	80	0.0211030389736873	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	CYP1A1; TH; GGT5; PLA2G4D; ACOT11; UGT1A8;	GO:0006631~fatty acid metabolic process	6	63	9.52380952380952	0.0215261196020198	0.143950564748965	1	1	0.999999169059752	0.999999169059752	1
up	PF4; IL10; CORO1A; GPR183; CXCR5; CNR2; PPBP; PF4V1; CXCL3;	GO:0030595~leukocyte chemotaxis	9	24	37.5	0.0221979310902738	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	HEXA; HEXB; GLB1; GALNS; PRELP; OMD;	GO:0042340~keratan sulfate catabolic process	6	12	50	0.0225002204705358	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	IL2RA; LYN; CTLA4; FCRLB; INPP5D; FOXP3;	GO:0050777~negative regulation of immune response	6	12	50	0.0225002204705358	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	CEACAM5; CEACAM6; LGALS7; NECTIN4; IGSF21;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	5	47	10.6382978723404	0.0235782701747486	0.151226247393289	1	1	0.999999169059752	0.999999169059752	1
down	CIDEA; ID1; ACOT11; HOXC10; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	5	47	10.6382978723404	0.0235782701747486	0.151226247393289	1	1	0.999999169059752	0.999999169059752	1
down	KRT14; S100A8; TH; GGH;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.0236314893290388	0.151226247393289	1	1	0.999999169059752	0.999999169059752	1
down	SLPI; CTSG; DEFB1; RNASE7;	GO:0019731~antibacterial humoral response	4	31	12.9032258064516	0.0236314893290388	0.151226247393289	1	1	0.999999169059752	0.999999169059752	1
down	S100A8; S100A9; TJP1; CAPN6;	GO:0051493~regulation of cytoskeleton organization	4	31	12.9032258064516	0.0236314893290388	0.151226247393289	1	1	0.999999169059752	0.999999169059752	1
down	WNT5A; FOXF1; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	3	17	17.6470588235294	0.0238223584537516	0.151226247393289	1	1	0.999999169059752	0.999999169059752	1
down	TH; CCND1; MAOB;	GO:0051412~response to corticosterone	3	17	17.6470588235294	0.0238223584537516	0.151226247393289	1	1	0.999999169059752	0.999999169059752	1
down	USH1G; HES5; ADGRV1;	GO:0060122~inner ear receptor cell stereocilium organization	3	17	17.6470588235294	0.0238223584537516	0.151226247393289	1	1	0.999999169059752	0.999999169059752	1
down	ESYT3; VLDLR; ABCA12; SPNS2; SLCO2A1; GULP1;	GO:0006869~lipid transport	6	65	9.23076923076923	0.0244087463712286	0.151226247393289	1	1	0.999999169059752	0.999999169059752	1
down	EFNA1; ITGA8; TYRO3; SRCIN1; LAMB4;	GO:0034446~substrate adhesion-dependent cell spreading	5	48	10.4166666666667	0.025380222624955	0.156332857526558	1	1	0.999999169059752	0.999999169059752	1
down	S100A6; MIF; AQP1; BTC; WNT5A;	GO:0048146~positive regulation of fibroblast proliferation	5	48	10.4166666666667	0.025380222624955	0.156332857526558	1	1	0.999999169059752	0.999999169059752	1
up	TRAV19; PSMB11; CD4; TRBV12-3; TRAV8-4; TRBC1; HLA-DRA; CD3D; TRBV7-9; TRAV29DV5; HLA-A; HLA-DPB1; CD3G; HLA-DPA1; GATA3; PSMA2; PSMB8; PSMB9; PSMB10; PSMB3; RELA; PSME1; RFTN1; TRAT1; SKAP1; NFKBID; PSMA8; PSMF1; INPP5D; RBCK1; PRKD2; FOXP3; CD276; BTN2A2; HHLA2; CTLA4; BTN1A1; BTNL8;	GO:0050852~T cell receptor signaling pathway	38	174	21.8390804597701	0.0256228831779842	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	SCNN1B; SCNN1G; UGT1A7; ATP6V0A4;	GO:0007588~excretion	4	32	12.5	0.0259408662156575	0.159493567556707	1	1	0.999999169059752	0.999999169059752	1
down	BMP2; BMP7; ID1; DLX5; SOSTDC1; DSG4; TMEM100;	GO:0030509~BMP signaling pathway	7	85	8.23529411764706	0.0262707021282539	0.161226228600637	1	1	0.999999169059752	0.999999169059752	1
down	C1QA; TFF1; CCND1;	GO:0010039~response to iron ion	3	18	16.6666666666667	0.0271558592885099	0.16396082667541	1	1	0.999999169059752	0.999999169059752	1
down	CTSV; CRYAB; TH;	GO:0010259~multicellular organism aging	3	18	16.6666666666667	0.0271558592885099	0.16396082667541	1	1	0.999999169059752	0.999999169059752	1
down	TMPRSS2; CTSE; KLK6;	GO:0016540~protein autoprocessing	3	18	16.6666666666667	0.0271558592885099	0.16396082667541	1	1	0.999999169059752	0.999999169059752	1
down	POU3F1; ADGRG6; PARD3;	GO:0022011~myelination in peripheral nervous system	3	18	16.6666666666667	0.0271558592885099	0.16396082667541	1	1	0.999999169059752	0.999999169059752	1
down	IL18; RAET1G; RAET1E;	GO:0042267~natural killer cell mediated cytotoxicity	3	18	16.6666666666667	0.0271558592885099	0.16396082667541	1	1	0.999999169059752	0.999999169059752	1
down	EDN2; NPNT; NMU;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.0271558592885099	0.16396082667541	1	1	0.999999169059752	0.999999169059752	1
down	TCF21; FOXF1; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	3	18	16.6666666666667	0.0271558592885099	0.16396082667541	1	1	0.999999169059752	0.999999169059752	1
down	SULT2B1; SULT1C2; SULT1E1;	GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process	3	18	16.6666666666667	0.0271558592885099	0.16396082667541	1	1	0.999999169059752	0.999999169059752	1
down	FGF1; FUT1; TJP1;	GO:1903672~positive regulation of sprouting angiogenesis	3	18	16.6666666666667	0.0271558592885099	0.16396082667541	1	1	0.999999169059752	0.999999169059752	1
up	IGHD; ORM1; ORM2; PANX3; HMGB1P1;	GO:0050716~positive regulation of interleukin-1 secretion	5	9	55.5555555555556	0.0272089706404839	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	ADCYAP1; FAM3B; PCLO; ANXA1;	GO:0030073~insulin secretion	4	33	12.1212121212121	0.028380964321739	0.170743543419494	1	1	0.999999169059752	0.999999169059752	1
down	BMP2; BMP7; DLX5; TMEM100;	GO:0071773~cellular response to BMP stimulus	4	33	12.1212121212121	0.028380964321739	0.170743543419494	1	1	0.999999169059752	0.999999169059752	1
down	S100A8; CCK; S100A9; XDH; FAM162A; BCL2L10; CASP14;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	7	87	8.04597701149425	0.029107977347014	0.17204485006051	1	1	0.999999169059752	0.999999169059752	1
down	PTN; CX3CL1; CNTN4; FGF14; PLK2;	GO:0048167~regulation of synaptic plasticity	5	50	10	0.0292426982975578	0.17204485006051	1	1	0.999999169059752	0.999999169059752	1
down	EGFL8; TFAP2B; HNF4A; HNF4G; TFAP2C;	GO:0048856~anatomical structure development	5	50	10	0.0292426982975578	0.17204485006051	1	1	0.999999169059752	0.999999169059752	1
up	HLA-DPB1; CCL2; HLA-DPA1; CCR2; FAM49B; SIRPG; PYCARD;	GO:0050870~positive regulation of T cell activation	7	17	41.1764705882353	0.0293972481546194	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	TNFRSF10A; TNFRSF10B; SP100; FASLG; TNFSF10; TRADD; TMC8;	GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors	7	17	41.1764705882353	0.0293972481546194	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	DLX3; DLX5; DLG2;	GO:0009790~embryo development	3	19	15.7894736842105	0.0307243649314647	0.17204485006051	1	1	0.999999169059752	0.999999169059752	1
down	MYO5B; MYO5C; MYO6;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.0307243649314647	0.17204485006051	1	1	0.999999169059752	0.999999169059752	1
down	PTN; PTPRZ1; HES5;	GO:0031641~regulation of myelination	3	19	15.7894736842105	0.0307243649314647	0.17204485006051	1	1	0.999999169059752	0.999999169059752	1
down	CIDEA; CIDEC; HILPDA;	GO:0034389~lipid droplet organization	3	19	15.7894736842105	0.0307243649314647	0.17204485006051	1	1	0.999999169059752	0.999999169059752	1
down	HOXD10; STRA6; HOXC10;	GO:0050905~neuromuscular process	3	19	15.7894736842105	0.0307243649314647	0.17204485006051	1	1	0.999999169059752	0.999999169059752	1
down	MAP2; VLDLR; PREX2; DCDC2;	GO:0048813~dendrite morphogenesis	4	34	11.7647058823529	0.030952862563657	0.172605913000327	1	1	0.999999169059752	0.999999169059752	1
down	FOXP2; HR; CRYAB; BMP2; BMP7; HOXA7; SOX18; ID1; WNT5A; HNF4A; ID4; PAX9; WNT4; PITX1; ELF3; FOXF2; NR0B2; KCTD1; ERN2; CIART; TFAP2B; ATOH8; SOX7; TRIM6; OVOL1; OVOL2;	GO:0045892~negative regulation of transcription, DNA-templated	26	530	4.90566037735849	0.0311721751133269	0.173540616675686	1	1	0.999999169059752	0.999999169059752	1
up	TNF; APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0315976422639812	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	HLA-B; HLA-A; HLA-E; SERPINB9;	GO:0042270~protection from natural killer cell mediated cytotoxicity	4	6	66.6666666666667	0.0315976422639812	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	ACOD1; CD14; SIRT2; FAM49B;	GO:0071219~cellular response to molecule of bacterial origin	4	6	66.6666666666667	0.0315976422639812	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	RGS9; IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	4	6	66.6666666666667	0.0315976422639812	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	CCL21; TNFRSF10B; APOL3; TNF; CD4; CD74; RHOC; LGALS1; TNFRSF1A; F2R; CASP1; CCR7; NUP62; FASLG; TNFSF10; TIRAP; RELA; IKBKE; IRF3; PRKD1; TRADD; CARD16; CLEC6A; SHISA5; TNIP2; SLC35B2; C18orf32; SECTM1; TMEM106A; LITAF; MYD88; RBCK1; TRIM8; SHARPIN; CARD9; NEK6; TLR9; TERF2IP; PIM2;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	39	183	21.3114754098361	0.0319607032568419	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	CCL21; CD74; RAC2; MDK; CCR7; XCL1; NCKAP1L; TIRAP; CAMK1D;	GO:0090023~positive regulation of neutrophil chemotaxis	9	26	34.6153846153846	0.0320178775452566	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	FUT3; PHLDA2; SRCIN1; CAMSAP3; RHOD; RND3; AMOTL2;	GO:0030334~regulation of cell migration	7	89	7.86516853932584	0.0321450461498003	0.178660463451787	1	1	0.999999169059752	0.999999169059752	1
down	ALOX15B; CIDEA; CH25H; UGT2B7; HNF4A; ALDH3B2; FABP5; MGLL; EPHX3;	GO:0006629~lipid metabolic process	9	130	6.92307692307692	0.0322741580340847	0.179081567802351	1	1	0.999999169059752	0.999999169059752	1
up	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	SIX1; PROX1; SIX4;	GO:0030910~olfactory placode formation	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	SAT2; SAT1; SATL1;	GO:0032918~spermidine acetylation	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	ADA; DPP4; FERMT3;	GO:0033632~regulation of cell-cell adhesion mediated by integrin	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	HLA-A; HLA-E; CLEC4A;	GO:0036037~CD8-positive, alpha-beta T cell activation	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	BCL3; GATA3; BATF;	GO:0045064~T-helper 2 cell differentiation	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	TUSC2; F2; ELANE;	GO:0070945~neutrophil-mediated killing of gram-negative bacterium	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	NECAB2; SHANK3; UNC13A;	GO:1900451~positive regulation of glutamate receptor signaling pathway	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	OAZ2; OAZ1; OAZ3;	GO:1902268~negative regulation of polyamine transmembrane transport	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	MAN1A2; MAN1A1; MAN1C1;	GO:1904381~Golgi apparatus mannose trimming	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	STK10; MSN; GCSAML;	GO:2000401~regulation of lymphocyte migration	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	HLA-B; CEBPB; LILRB2;	GO:2001198~regulation of dendritic cell differentiation	3	3	100	0.0326224333993752	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	CCND1; ID4; ANGPTL8; ADGRF5; TFAP2B; ALOXE3;	GO:0045444~fat cell differentiation	6	70	8.57142857142857	0.0327106662233273	0.18090561204565	1	1	0.999999169059752	0.999999169059752	1
down	WNT9B; WNT5A; WNT4; WNT7B; WNT2B; FZD10;	GO:0060070~canonical Wnt signaling pathway	6	70	8.57142857142857	0.0327106662233273	0.18090561204565	1	1	0.999999169059752	0.999999169059752	1
up	CIB2; ADCY5; S1PR4; KNG1; OXT; CALCA; CD55; GATA2; EDNRA; F2R; CD52; GLP1R; CAV3; IL2; C1QTNF1; PROK2; GPR35; TRPC5; PTGER4; PTGDR; ADRA1D; CCR10; TBXA2R; FPR3; CXCR3; CCR7; CCR8; CCR6; CCR5; CXCR5; PTGIR; CCR2; CXCR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	33	150	22	0.0328568229421312	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	BMP7; HNF4A; ESRRG; HNF4G; NR0B2;	GO:0043401~steroid hormone mediated signaling pathway	5	52	9.61538461538462	0.0334567764071885	0.184424299505635	1	1	0.999999169059752	0.999999169059752	1
down	ARHGEF15; WNT4; SYNPO2L; NOX4; LIMCH1;	GO:0051496~positive regulation of stress fiber assembly	5	52	9.61538461538462	0.0334567764071885	0.184424299505635	1	1	0.999999169059752	0.999999169059752	1
down	IDO1; RAET1L; CD300LG; IRF6;	GO:0002376~immune system process	4	35	11.4285714285714	0.0336573987405155	0.184620731326651	1	1	0.999999169059752	0.999999169059752	1
down	DEFB4A; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.0336573987405155	0.184620731326651	1	1	0.999999169059752	0.999999169059752	1
down	PTPN3; BTC; EPGN; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	4	35	11.4285714285714	0.0336573987405155	0.184620731326651	1	1	0.999999169059752	0.999999169059752	1
up	AKT1; NUP62; FASLG; CCDC88A; SHKBP1; DOK1; PDE6H; PDE6G;	GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway	8	22	36.3636363636364	0.0343938661063523	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	LILRA5; IFNG; ORM1; LPL; IFNGR1; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	8	22	36.3636363636364	0.0343938661063523	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	EPCAM; HNF4A; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.034526249908104	0.188769740947077	1	1	0.999999169059752	0.999999169059752	1
down	GJA1; ADCYAP1; NPPC;	GO:0097755~positive regulation of blood vessel diameter	3	20	15	0.034526249908104	0.188769740947077	1	1	0.999999169059752	0.999999169059752	1
down	FOXN1; TREH; TH; BMP2; ELN; PHLDA2; LAMB4; EGFLAM;	GO:0009887~animal organ morphogenesis	8	111	7.20720720720721	0.0348524698099133	0.190243481547771	1	1	0.999999169059752	0.999999169059752	1
down	GALNT18; A4GNT; B3GALT5; B3GNT6; B3GNT3;	GO:0006493~protein O-linked glycosylation	5	53	9.43396226415094	0.0356978547913802	0.193912133551235	1	1	0.999999169059752	0.999999169059752	1
down	FOXH1; FOXF1; IL1F10; IL1RL2; CRNN;	GO:0071345~cellular response to cytokine stimulus	5	53	9.43396226415094	0.0356978547913802	0.193912133551235	1	1	0.999999169059752	0.999999169059752	1
down	RAMP3; AGR2; EPHA2; PLS1; ARHGEF16;	GO:1903078~positive regulation of protein localization to plasma membrane	5	53	9.43396226415094	0.0356978547913802	0.193912133551235	1	1	0.999999169059752	0.999999169059752	1
up	PPEF2; SMAD7; CALM2; CALM3; SIRT2; INPP5K; SPRED3;	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	7	18	38.8888888888889	0.0363664218165924	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	HES5; TFAP2B; KLK6; BCL6B;	GO:0045595~regulation of cell differentiation	4	36	11.1111111111111	0.0364951749087394	0.195052514311321	1	1	0.999999169059752	0.999999169059752	1
down	FOXA1; TTC23; DCDC2; INTU;	GO:0045880~positive regulation of smoothened signaling pathway	4	36	11.1111111111111	0.0364951749087394	0.195052514311321	1	1	0.999999169059752	0.999999169059752	1
up	HLA-E; HLA-F; CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	5	10	50	0.0365332430068758	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	MET; PRKD1; P2RX4; PRKD2; SMOC2;	GO:2001028~positive regulation of endothelial cell chemotaxis	5	10	50	0.0365332430068758	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	CD276; IL27; IL21; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	6	14	42.8571428571429	0.0374179351039582	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	RASGRP1; CD4; DBH; LIPA; BATF; FOXP3; NFATC1; NFATC4; NFATC3;	GO:0001816~cytokine production	9	27	33.3333333333333	0.0379087870301511	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	TNF; IFNG; IL10; PTGER4; IRF3; CLEC6A; RGCC; IL26; CD14;	GO:0050715~positive regulation of cytokine secretion	9	27	33.3333333333333	0.0379087870301511	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	BMP2; KDR; WNT5A; CCL11; ECM1; NRARP;	GO:0001938~positive regulation of endothelial cell proliferation	6	73	8.21917808219178	0.0384748773092806	0.197623465284847	1	1	0.999999169059752	0.999999169059752	1
down	TYRO3; KDR; ERBB3; EPHA2; MST1R; FGFR3;	GO:0033674~positive regulation of kinase activity	6	73	8.21917808219178	0.0384748773092806	0.197623465284847	1	1	0.999999169059752	0.999999169059752	1
up	F13A1; TIMP1; TNF; IL2RA; CD4; IGHE; PF4; IL5; FCER2; CSF1R; VIM; CSF3; CCL2; OSM; ALOX15; VCAM1; TNFRSF1A; TNFRSF1B; IL10; GATA3; PTPN6; CASP1; TYK2; AKT1; IL2RG; CD80; OPRM1; FLT3; OPRD1; CCR2; STAT5A; FASLG; CEBPD; RORC; CCR5; IL2; GRB2; IL5RA; RELA; IRF4; BATF; STX1A; IL31; IL31RA; INPP5D; IL22; GREM2; IL26; IL20; IFNA21; IFNGR1; IFNA5; IFNB1; IFNGR2; IFNAR2;	GO:0019221~cytokine-mediated signaling pathway	55	278	19.7841726618705	0.038490584623765	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	PLPP2; FUT3; FUT6;	GO:0006672~ceramide metabolic process	3	21	14.2857142857143	0.0385592403221848	0.197623465284847	1	1	0.999999169059752	0.999999169059752	1
down	SCEL; CAMSAP3; STOX2;	GO:0009792~embryo development ending in birth or egg hatching	3	21	14.2857142857143	0.0385592403221848	0.197623465284847	1	1	0.999999169059752	0.999999169059752	1
down	EDN3; EDNRB; OCA2;	GO:0030318~melanocyte differentiation	3	21	14.2857142857143	0.0385592403221848	0.197623465284847	1	1	0.999999169059752	0.999999169059752	1
down	KLK8; WNT5A; CDH8;	GO:0050807~regulation of synapse organization	3	21	14.2857142857143	0.0385592403221848	0.197623465284847	1	1	0.999999169059752	0.999999169059752	1
down	SAA1; TYRO3; FOXF1; FFAR4; CXCL17; IL22RA2; FNDC4;	GO:0050728~negative regulation of inflammatory response	7	93	7.52688172043011	0.0388374955440236	0.198746147166596	1	1	0.999999169059752	0.999999169059752	1
down	DLX3; GJB3; ETNK2; PHLDA2;	GO:0001890~placenta development	4	37	10.8108108108108	0.0394665632487773	0.201133237003243	1	1	0.999999169059752	0.999999169059752	1
down	SOX18; HES5; ANGPTL8; CCL19;	GO:0048469~cell maturation	4	37	10.8108108108108	0.0394665632487773	0.201133237003243	1	1	0.999999169059752	0.999999169059752	1
down	ADRA2A; HNF4A; PRKAA2; FOXA1; FAM3B; FABP5; ADGRF5; TFAP2B;	GO:0042593~glucose homeostasis	8	114	7.01754385964912	0.0394837066384085	0.201133237003243	1	1	0.999999169059752	0.999999169059752	1
down	KLK13; CPZ; CPXM2; CPXM1; CPE;	GO:0016485~protein processing	5	55	9.09090909090909	0.0404515842395127	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	DHCR24; DUOXA1; DUOXA2; PHYHIP; WNK4; PARD3;	GO:0008104~protein localization	6	74	8.10810810810811	0.0405307544374822	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	SOD3; GPX2; GPX3; GJB2; PRKAA2; NOX5; NOX4;	GO:0034599~cellular response to oxidative stress	7	94	7.4468085106383	0.0406424914504679	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
up	TNF; IFNB1; IFNG; IFITM1; CCDC130; IFNGR1; BCL3; CFL1; GATA3; PSMA2; IFNGR2; XCL1; IFNAR2; HMGA2; NPC2; CCL8; IFITM2; LILRB1; ISG20; FOXP3; BATF3; TLR8; PIM2; TBX21;	GO:0009615~response to virus	24	104	23.0769230769231	0.0416833010775995	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	SRRM4; ESRP1; ESRP2; RBM20;	GO:0043484~regulation of RNA splicing	4	38	10.5263157894737	0.0425717123583058	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	EPHA2; KDR; TYRO3; TMEM100;	GO:0043491~protein kinase B signaling	4	38	10.5263157894737	0.0425717123583058	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	RBP1; HNF4A; ABCA12; ACOX2;	GO:0055088~lipid homeostasis	4	38	10.5263157894737	0.0425717123583058	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	PTN; TM4SF4; KLK6;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.0428204725230785	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	BRINP1; CCL11; PRTG;	GO:0050768~negative regulation of neurogenesis	3	22	13.6363636363636	0.0428204725230785	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	GSTA4; GSTA1; GSTM3;	GO:1901687~glutathione derivative biosynthetic process	3	22	13.6363636363636	0.0428204725230785	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
up	SH2B2; F13A1; F2; F10; PLG; PLAU; IFNA21; IFNA5; IFNB1; HBD; F11; GP1BA; LYN; TFPI; IRF1; IRF2; GP9; GATA1; GATA2; GATA3; F2R; FCER1G; GP5; CAPZB; P2RX1; HBG1; HBG2; GNA12; NFE2; HPS6; DTNBP1; P2RX4; VKORC1; EHD1; HMG20B; SERPINA10;	GO:0007596~blood coagulation	36	171	21.0526315789474	0.0432354217228443	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	IL2RA; CD74; MDK; GATA3; CD27; RHOH; PIK3R6;	GO:0045582~positive regulation of T cell differentiation	7	19	36.8421052631579	0.0443413174813387	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	HOXD3; ITGA8; EMP2; NPNT; LYPD5; ITGBL1; LYPD3;	GO:0007160~cell-matrix adhesion	7	96	7.29166666666667	0.0444139486212203	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
up	OAZ2; SAT1; OAZ1; OAZ3;	GO:0006596~polyamine biosynthetic process	4	7	57.1428571428571	0.0446358475057328	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	TAZ; PGS1; SLC27A1; PTPMT1;	GO:0032049~cardiolipin biosynthetic process	4	7	57.1428571428571	0.0446358475057328	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	LPXN; GPS2; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.0446358475057328	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	CCL21; AXL; CCR7; LILRB1;	GO:2000669~negative regulation of dendritic cell apoptotic process	4	7	57.1428571428571	0.0446358475057328	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	CLEC3B; BMP7; NPPC; STC1; ECM1; ATP6V0A4;	GO:0001503~ossification	6	76	7.89473684210526	0.0448473243800787	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	CCND1; SLC6A1; TNNT2; AQP3; S100A16;	GO:0051592~response to calcium ion	5	57	8.7719298245614	0.0455708961286595	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	DHCR24; EGFLAM; BARX2; LAMB4;	GO:0009888~tissue development	4	39	10.2564102564103	0.0458105539132607	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	RGS11; ERBB3; PTK6; RGS7BP;	GO:0009968~negative regulation of signal transduction	4	39	10.2564102564103	0.0458105539132607	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	EFNA1; ERBB3; SRCIN1; NOX4;	GO:0061098~positive regulation of protein tyrosine kinase activity	4	39	10.2564102564103	0.0458105539132607	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	MAP2; CAMSAP3; PARD3; TACC2; TUBB6; TUBAL3; CALML3; CALML5;	GO:0000226~microtubule cytoskeleton organization	8	118	6.77966101694915	0.046271861290433	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
up	GATA3; XCL1; HDAC7; FOXP3; HOMER3; TBX21;	GO:0032703~negative regulation of interleukin-2 production	6	15	40	0.0467820539517283	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	IFNG; IL2RA; CTLA4; IL2; FOXP3; TNFRSF18;	GO:0045589~regulation of regulatory T cell differentiation	6	15	40	0.0467820539517283	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
up	SPINK1; SLC8B1; SARAF; JPH4; CD84; HOMER3;	GO:2001256~regulation of store-operated calcium entry	6	15	40	0.0467820539517283	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	FOXP2; WNT5A; FOXF1;	GO:0002053~positive regulation of mesenchymal cell proliferation	3	23	13.0434782608696	0.0473065482146603	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	FABP12; FABP5; MGLL;	GO:0019433~triglyceride catabolic process	3	23	13.0434782608696	0.0473065482146603	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	ARHGEF25; EPS8L1; EPS8L2;	GO:0035023~regulation of Rho protein signal transduction	3	23	13.0434782608696	0.0473065482146603	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	CCK; TH; NMU;	GO:0042755~eating behavior	3	23	13.0434782608696	0.0473065482146603	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	VSNL1; EXPH5; CADPS2;	GO:0045921~positive regulation of exocytosis	3	23	13.0434782608696	0.0473065482146603	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	MMP12; CCL19; TRIM6;	GO:0098586~cellular response to virus	3	23	13.0434782608696	0.0473065482146603	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
up	TK2; TYMP; DCK; PUDP; UCK1;	GO:0043097~pyrimidine nucleoside salvage	5	11	45.4545454545455	0.0475909696008199	0.924305363488163	1	1	0.999999410221451	0.99999941022145	1
down	ARHGAP32; RHOD; TRIP10; ARHGAP40; ARHGEF16; NGEF; RHOV; ARHGEF4; ARHGAP28;	GO:0051056~regulation of small GTPase mediated signal transduction	9	141	6.38297872340426	0.0484866883240468	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	PRKAA2; HMGCS2; DHCR24; NPC1L1;	GO:0006695~cholesterol biosynthetic process	4	40	10	0.0491828096409902	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
down	SCGB1A1; PRLR; STC1; EMP2;	GO:0007566~embryo implantation	4	40	10	0.0491828096409902	0.205704558349401	1	1	0.999999169059752	0.999999169059752	1
